{"meta":{"query_hash":"8eb2886c511c","filters":{"venue":"Hematology Transfusion and Cell Therapy"},"cohort_total":62,"direct_labels_cover":0,"predictions_cover":62,"exported":62,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/8eb2886c511c","api":"https://metacan.xera.ac/api/v1/cohort?venue=Hematology+Transfusion+and+Cell+Therapy"},"results":[{"id":"W2935251294","doi":"10.1016/j.htct.2018.11.007","title":"CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemia","year":2019,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute","funders":"Fundação Oswaldo Cruz; Fundação do Câncer; Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Científico e Tecnológico","keywords":"Flow cytometry; Medicine; ETV6; Cutoff; Leukemia; B cell; Lymphoblastic Leukemia; Fusion gene; Cell; Internal medicine; Molecular biology; Oncology; Cancer research; Immunology; Gene; Biology; Chromosomal translocation; Genetics; Antibody","score_opus":0.007441038805008407,"score_gpt":0.24096268012063124,"score_spread":0.23352164131562284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2935251294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810353,0.0026640692,0.00033084204,0.0006134124,0.0002457878,0.0015654085,0.000012650824,0.00012023081,0.0134123145],"genre_scores_gemma":[0.98077965,0.013873689,0.00034443673,0.0012488563,0.00005323254,0.00008978201,0.000037821846,0.00007944269,0.0034931197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973217,0.00015453527,0.0005249006,0.0007757496,0.00045963578,0.00076345424],"domain_scores_gemma":[0.9986681,0.00030096696,0.00008388042,0.0005253642,0.00007147344,0.00035024315],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002746784,0.0004080146,0.00085826905,0.00034852486,0.00008981388,0.000023107226,0.00022563327,0.00052451354,0.0011373397],"category_scores_gemma":[0.000014000909,0.0003267461,0.00015117455,0.00039850845,0.00018924734,0.00010897705,0.00005036684,0.00055582856,0.0003680427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020710567,0.008528369,0.22773948,0.0028181965,0.000892271,0.0031051384,0.02105074,0.00010648345,0.66947305,0.0019791706,0.009407451,0.034189053],"study_design_scores_gemma":[0.2388576,0.01045733,0.11664285,0.0015103893,0.0005161995,0.008030425,0.0019426135,0.01683922,0.57752824,0.0012804721,0.024008771,0.0023859101],"about_ca_topic_score_codex":0.00007699812,"about_ca_topic_score_gemma":0.00002234341,"teacher_disagreement_score":0.21814702,"about_ca_system_score_codex":0.00029827622,"about_ca_system_score_gemma":0.00095580745,"threshold_uncertainty_score":0.99991846},"labels":[],"label_agreement":null},{"id":"W2951183316","doi":"10.1016/j.htct.2019.03.005","title":"The impact of multiple myeloma induction therapy on hematopoietic stem cell mobilization and collection: 25-year experience","year":2019,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Bortezomib; Multiple myeloma; Cyclophosphamide; Dexamethasone; Internal medicine; Regimen; Hematopoietic stem cell transplantation; Granulocyte colony-stimulating factor; Oncology; CD34; Surgery; Transplantation; Stem cell; Chemotherapy","score_opus":0.023044340847318556,"score_gpt":0.2951353711433874,"score_spread":0.27209103029606885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951183316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950736,0.002620293,0.000049424896,0.00014044128,0.00008396131,0.0012063325,0.0000030471222,0.000029412144,0.0007934975],"genre_scores_gemma":[0.9752907,0.023900688,0.000035735742,0.000036741298,0.000012550094,0.000075887634,0.0000076277097,0.000020559854,0.00061947166],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988633,0.00013134594,0.00024295483,0.00031541093,0.00021115245,0.00023587393],"domain_scores_gemma":[0.99923843,0.00020814103,0.000077394434,0.00027183877,0.00007969553,0.00012447734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013307268,0.00018964548,0.00033162796,0.00010348808,0.00022923684,0.000018722007,0.000056581328,0.00014499779,0.00021064634],"category_scores_gemma":[0.0000037105647,0.000109768145,0.00009835592,0.00021152328,0.00015956597,0.000057517584,0.0000089468,0.00015547023,0.000011172997],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009549454,0.0014814123,0.6038823,0.00016555436,0.00015976478,0.000017355089,0.010280274,0.0000101648475,0.32919043,0.00020856623,0.00014461076,0.044910084],"study_design_scores_gemma":[0.022167359,0.007117309,0.28173822,0.000103013794,0.000016674467,0.00028313234,0.0044037006,0.0013977309,0.6818085,0.00009974699,0.0006056058,0.00025900741],"about_ca_topic_score_codex":0.000099597535,"about_ca_topic_score_gemma":0.000009725113,"teacher_disagreement_score":0.35261807,"about_ca_system_score_codex":0.000029991195,"about_ca_system_score_gemma":0.000060017657,"threshold_uncertainty_score":0.4476215},"labels":[],"label_agreement":null},{"id":"W2981474191","doi":"10.1016/j.htct.2019.08.001","title":"The existing scenario of haemophilia care in Canada and China - A review","year":2019,"lang":"en","type":"review","venue":"Hematology Transfusion and Cell Therapy","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Haemophilia; Reimbursement; Health care; China; Developing country; Medicine; Government (linguistics); Developed country; Business; Economic growth; Political science; Pediatrics; Environmental health; Economics; Population","score_opus":0.05377595264533774,"score_gpt":0.3413994454570675,"score_spread":0.2876234928117298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981474191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038977237,0.99242187,2.1722639e-7,0.00041098657,0.00007650521,0.0018568027,0.000009486886,0.000005525132,0.0013208777],"genre_scores_gemma":[0.00051294785,0.9987729,0.000013394357,0.00009482474,0.000012945682,0.000057432142,0.000034257686,0.000027014476,0.00047427375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841815,0.00022418426,0.00054170337,0.00033510334,0.00020267935,0.00027815148],"domain_scores_gemma":[0.9991548,0.00026913185,0.00011909155,0.00031480892,0.000040588544,0.00010156774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024488012,0.00028816875,0.0019232923,0.000080884056,0.00010181842,0.00000547573,0.000103749575,0.00019012865,0.000063005595],"category_scores_gemma":[0.00001305799,0.00014841641,0.00015796314,0.0001932937,0.00012320223,0.00001148228,0.000022167405,0.000458391,0.0000019413314],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053860163,0.000034702938,0.0010081208,0.09341381,0.00005916609,0.00010245999,0.00020888733,4.3821595e-9,0.0000022398349,0.000033490407,0.000111982095,0.9049713],"study_design_scores_gemma":[0.0016454214,0.00026071243,0.00018099343,0.05522823,0.00031830056,0.0005541005,0.00015899376,0.0000023012242,0.000032138614,0.000010157481,0.9414112,0.00019747074],"about_ca_topic_score_codex":0.0765248,"about_ca_topic_score_gemma":0.18147765,"teacher_disagreement_score":0.9412992,"about_ca_system_score_codex":0.00008928756,"about_ca_system_score_gemma":0.0015259648,"threshold_uncertainty_score":0.9296247},"labels":[],"label_agreement":null},{"id":"W3033092504","doi":"10.1016/j.htct.2020.03.005","title":"Bone marrow necrosis in a patient with advanced Hodgkin's lymphoma after G-CSF and Plerixafor treatment during harvesting for autologous bone marrow transplantation: is it possible?","year":2020,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Plerixafor; Medicine; Lymphoma; Bone marrow; Bone marrow transplantation; Transplantation; Surgery; Pathology; Immunology; CXCR4; Immune system","score_opus":0.011517551316940003,"score_gpt":0.234494007402898,"score_spread":0.222976456085958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033092504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875772,0.0048103547,0.00026543453,0.0058250744,0.00004044927,0.00115784,0.00009187588,0.000048982907,0.00018278141],"genre_scores_gemma":[0.98599505,0.00995988,0.0012597361,0.0021514026,0.000026643493,0.00039295942,0.000038851445,0.00003860733,0.00013686843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986207,0.000046078265,0.00036354468,0.00051605445,0.000120061115,0.00033357486],"domain_scores_gemma":[0.9994732,0.000053339387,0.00007438756,0.0001235183,0.00004313483,0.00023239535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000405039,0.00030111047,0.00059405516,0.00009005937,0.00014691807,0.000024676874,0.000031471485,0.00014738309,0.00013194108],"category_scores_gemma":[0.000002837528,0.00023052965,0.000116467796,0.0001235178,0.000108327826,0.00011163176,0.0000066283897,0.00007926762,0.0000014509204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3778862,0.0026485051,0.03504997,0.006676629,0.00030544013,0.007732522,0.052239347,0.000023388957,0.3998657,0.00016365123,0.00013473541,0.11727391],"study_design_scores_gemma":[0.16528882,0.105581924,0.09553006,0.005252974,0.0015493098,0.017037993,0.009245575,0.0063150213,0.58105737,0.00024366529,0.0098017305,0.003095574],"about_ca_topic_score_codex":0.00006328337,"about_ca_topic_score_gemma":0.000057989066,"teacher_disagreement_score":0.21259737,"about_ca_system_score_codex":0.000036528603,"about_ca_system_score_gemma":0.000061470644,"threshold_uncertainty_score":0.94007266},"labels":[],"label_agreement":null},{"id":"W3035893698","doi":"10.1016/j.htct.2020.04.008","title":"Nutritional status at diagnosis among children with cancer referred to a nutritional service in Brazil","year":2020,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Malnutrition; Overweight; Hazard ratio; Body mass index; Proportional hazards model; Confidence interval; Outpatient clinic; Pediatrics; Cancer; Anthropometry; Internal medicine","score_opus":0.026365658186124314,"score_gpt":0.29181826001473915,"score_spread":0.26545260182861485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035893698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93902993,0.0039950456,0.000047525635,0.055534683,0.00003978257,0.0009483298,0.00012722566,0.0000654298,0.0002120723],"genre_scores_gemma":[0.9447298,0.013537785,0.00040105334,0.04056967,0.00010807346,0.00041666874,0.00016826937,0.000036945767,0.000031756063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983573,0.00010541237,0.00034028006,0.00052766287,0.00032822503,0.00034112274],"domain_scores_gemma":[0.9991711,0.00010690256,0.000054164855,0.00014992358,0.000077648416,0.000440292],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009183351,0.00023372754,0.00053641375,0.00010757125,0.00010837555,0.000011605846,0.00007963603,0.0001549908,0.0015639698],"category_scores_gemma":[0.000006501751,0.00020443783,0.000065728775,0.00042091208,0.00008823505,0.00006655746,0.000021465612,0.0002576603,0.000016769636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039701196,0.0006954159,0.98521465,0.00022651374,0.00008469192,0.00003415149,0.004734299,0.0000050155872,0.0020265658,0.00010066547,0.0023104483,0.0005974465],"study_design_scores_gemma":[0.01596186,0.0007157978,0.9612095,0.0003808752,0.000038813618,0.00011322862,0.00035417607,0.000022065027,0.013817171,0.000071768394,0.007003211,0.00031156858],"about_ca_topic_score_codex":0.0014307075,"about_ca_topic_score_gemma":0.0064277644,"teacher_disagreement_score":0.0240052,"about_ca_system_score_codex":0.000056126115,"about_ca_system_score_gemma":0.000115407434,"threshold_uncertainty_score":0.99934876},"labels":[],"label_agreement":null},{"id":"W3085568508","doi":"10.1016/j.htct.2020.07.007","title":"Cyclophosphamide-glucocorticoids versus lenalidomide-dexamethasone as treatment for multiple myeloma at first relapse after autologous stem cell transplantation – a retrospective analysis","year":2020,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Lenalidomide; Medicine; Multiple myeloma; Autologous stem-cell transplantation; Cyclophosphamide; Dexamethasone; Internal medicine; Oncology; Adverse effect; Transplantation; Bortezomib; Retrospective cohort study; Single Center; Surgery; Chemotherapy","score_opus":0.027019900958503717,"score_gpt":0.2806866787613068,"score_spread":0.2536667778028031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085568508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894901,0.0042453865,0.0016220197,0.0016796703,0.00009739346,0.0022030917,0.0001288566,0.00013029066,0.00040321948],"genre_scores_gemma":[0.9735947,0.023585754,0.00084552716,0.0003333334,0.000037524434,0.0007854879,0.00019945507,0.00005429594,0.0005639239],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99766564,0.00013676524,0.00048315502,0.00087129686,0.00030041306,0.000542738],"domain_scores_gemma":[0.998424,0.00052080024,0.000117572534,0.00031423065,0.0001051227,0.00051828707],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000107967266,0.00044364162,0.0010540657,0.00019702461,0.00031116302,0.000023147792,0.000081299,0.00029852035,0.00059188274],"category_scores_gemma":[0.00001567641,0.00034131756,0.0005201078,0.00045826458,0.00015524605,0.00007229476,0.0000134933,0.00017544848,0.000051592287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20198143,0.0020403736,0.7252162,0.00062407483,0.003365879,0.0021005033,0.011908829,0.00003578503,0.03191917,0.00006940559,0.00008307707,0.02065526],"study_design_scores_gemma":[0.13949576,0.016723994,0.33877605,0.00006929169,0.003870883,0.00029368146,0.0009814331,0.003679633,0.49166802,0.000050233004,0.0035803441,0.0008106769],"about_ca_topic_score_codex":0.00019387223,"about_ca_topic_score_gemma":0.00057268166,"teacher_disagreement_score":0.45974883,"about_ca_system_score_codex":0.00020020675,"about_ca_system_score_gemma":0.00008584705,"threshold_uncertainty_score":0.99990386},"labels":[],"label_agreement":null},{"id":"W3092074648","doi":"10.1016/j.htct.2020.08.013","title":"Cost-effectiveness of the regimen proposed by the International Consortium on Acute Promyelocytic Leukemia for the treatment of newly diagnosed patients with Acute Promyelocytic Leukemia","year":2020,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Acute promyelocytic leukemia; Medicine; Regimen; Leukemia; Acute leukemia; Oncology; Intensive care medicine; Internal medicine; Retinoic acid; Biology","score_opus":0.013562859564311708,"score_gpt":0.2481922240345656,"score_spread":0.23462936447025387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092074648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931918,0.0010683938,0.0016069944,0.00067509984,0.00010715302,0.0031588594,0.00006411354,0.000009014037,0.00011860592],"genre_scores_gemma":[0.9939623,0.004838056,0.000059641097,0.0003609343,0.000028905128,0.0004783525,0.00008751097,0.000028278171,0.00015605986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987931,0.0001692041,0.00026912356,0.0003797332,0.00019695706,0.0001918567],"domain_scores_gemma":[0.9990874,0.00020052317,0.00019412299,0.00032835815,0.00013905938,0.000050529467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001286678,0.00024645755,0.000315673,0.000015214672,0.00018103138,0.000014979631,0.00038326366,0.00015393921,0.000011837944],"category_scores_gemma":[0.000013735747,0.0001101457,0.00013988295,0.00009910265,0.00041869952,0.000005812326,0.000023837247,0.00010299198,4.7003348e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017293246,0.00076647254,0.012785244,0.00033080945,0.0016910337,0.000008185677,0.0021181325,0.00014965337,0.9506036,0.0003003564,0.00078313757,0.013170152],"study_design_scores_gemma":[0.009681475,0.0033591127,0.0012823599,0.000042914253,0.00018182497,0.000014458592,0.0001559527,0.00021089986,0.9775302,0.000035626326,0.007358136,0.00014706199],"about_ca_topic_score_codex":0.00001766297,"about_ca_topic_score_gemma":0.000004951362,"teacher_disagreement_score":0.026926601,"about_ca_system_score_codex":0.00006824971,"about_ca_system_score_gemma":0.00035240856,"threshold_uncertainty_score":0.44916114},"labels":[],"label_agreement":null},{"id":"W3094460179","doi":"10.1016/j.htct.2020.09.112","title":"Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura","year":2020,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Platelet; Complete remission; Internal medicine; Thrombotic thrombocytopenic purpura; Complete response; Gastroenterology; Surgery; Chemotherapy","score_opus":0.017492100287721093,"score_gpt":0.22010618899197743,"score_spread":0.20261408870425635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094460179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533534,0.0018850209,0.00003597752,0.001194354,0.000056921614,0.001206221,0.00010017829,0.000050558596,0.00013543793],"genre_scores_gemma":[0.9987557,0.00059781445,0.00008485938,0.0003252981,0.0000049924947,0.00004423318,0.00007465287,0.000025195939,0.00008724492],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982345,0.0003637332,0.00034766312,0.0006126967,0.00008151624,0.00035987629],"domain_scores_gemma":[0.9992505,0.00021869167,0.0001036831,0.0002598079,0.00005895742,0.00010836358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015778161,0.00031735687,0.0007045449,0.000098512144,0.00023600708,0.000032586002,0.00018793652,0.0001654474,0.0006407013],"category_scores_gemma":[0.000017494522,0.00022301816,0.000022885875,0.000174595,0.00026877737,0.0001125227,0.0000736742,0.00016439821,0.000020350732],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04550606,0.00077951304,0.18890993,0.00039532947,0.000317185,0.000051361625,0.0076979483,0.000003656846,0.7480584,0.00014523462,0.0011073942,0.0070279967],"study_design_scores_gemma":[0.09603402,0.01793074,0.7337258,0.0012231804,0.00019484783,0.0004301446,0.004456043,0.00012724951,0.13487512,0.00017631917,0.0085111745,0.0023153725],"about_ca_topic_score_codex":0.0000715523,"about_ca_topic_score_gemma":0.000093275456,"teacher_disagreement_score":0.61318326,"about_ca_system_score_codex":0.000017332908,"about_ca_system_score_gemma":0.000063252024,"threshold_uncertainty_score":0.90944165},"labels":[],"label_agreement":null},{"id":"W3096722156","doi":"10.1016/j.htct.2020.10.454","title":"POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE AFTER 1 PRIOR LINE OF THERAPY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF OPTIMMISM BY AGE, PRIOR TRANSPLANT, AND HIGH-RISK CYTOGENETICS","year":2020,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Fleurimont; Centre Hospitalier Universitaire de Sherbrooke; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Pomalidomide; Bortezomib; Medicine; Oncology; Multiple myeloma; Internal medicine; Dexamethasone; Refractory (planetary science); Lenalidomide; Cytogenetics; Biology; Chromosome","score_opus":0.018030600615336935,"score_gpt":0.2509549417080469,"score_spread":0.23292434109270996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096722156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97577685,0.022183528,0.00041471788,0.00051330304,0.000029859371,0.00093136483,0.00010053204,0.000030369318,0.000019499505],"genre_scores_gemma":[0.8373377,0.15966035,0.0023828251,0.0003865834,0.000015051477,0.000047101184,0.000047380643,0.000046672256,0.000076377175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978088,0.00024374337,0.0008334961,0.00057382137,0.00023960837,0.00030052094],"domain_scores_gemma":[0.99875945,0.0003904373,0.00024530134,0.00033229863,0.000055351735,0.00021714617],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021177392,0.00036819972,0.0013185426,0.00016761295,0.000049986622,0.000005391048,0.00010387589,0.00037529954,0.00034718122],"category_scores_gemma":[0.000023742823,0.00027194165,0.00016194119,0.00032955012,0.00026181535,0.0000361197,0.000012792194,0.00033907592,0.0000012186125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048710003,0.0021422477,0.3260586,0.0006130798,0.0007778542,0.0006587696,0.008366149,0.000016282438,0.54696655,0.000006155213,0.00006660285,0.06561768],"study_design_scores_gemma":[0.09005807,0.006095936,0.082537904,0.00024083754,0.0005896614,0.00016452558,0.0003930798,0.0013824359,0.81683767,0.000017531562,0.0012057291,0.00047663107],"about_ca_topic_score_codex":0.00036835516,"about_ca_topic_score_gemma":0.00023632732,"teacher_disagreement_score":0.2698711,"about_ca_system_score_codex":0.000037082737,"about_ca_system_score_gemma":0.00013475996,"threshold_uncertainty_score":0.9999733},"labels":[],"label_agreement":null},{"id":"W3131512256","doi":"10.1016/j.htct.2020.10.968","title":"Diagnosis of indolent systemic mastocytosis in a patient with “seborrheic keratosis”","year":2021,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surrey Memorial Hospital; Royal Columbian Hospital","funders":"University of British Columbia","keywords":"Seborrheic keratosis; Dermatology; Systemic mastocytosis; Medicine; Keratosis; Pathology","score_opus":0.007262163238993306,"score_gpt":0.19290267451033793,"score_spread":0.18564051127134462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131512256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96000713,0.038273226,0.0000735064,0.000184991,0.00012589687,0.00028261065,0.00001385581,0.000018170727,0.0010206274],"genre_scores_gemma":[0.9754144,0.023986401,0.00006084759,0.00018407586,0.0000026836394,0.00011401147,0.000026231688,0.000015602021,0.00019576815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879867,0.00021376181,0.0003730701,0.0003327688,0.000039072107,0.00024265265],"domain_scores_gemma":[0.99951315,0.00010017824,0.000091796166,0.00020738629,0.000060669783,0.000026822045],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008160592,0.00018372189,0.0005180189,0.00011592394,0.00007272674,0.0000050673552,0.00006878125,0.00022463134,0.001170408],"category_scores_gemma":[0.0000025178012,0.0001415446,0.0000640284,0.00018916289,0.00014571148,0.000025720332,0.000018090652,0.00019424628,0.000015679363],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015319065,0.0019500845,0.10601209,0.00049075467,0.00016141594,0.00030293548,0.007557378,0.000009742585,0.8471078,0.0015257673,0.0002864205,0.033063676],"study_design_scores_gemma":[0.0055487547,0.0006240196,0.002552974,0.0002832865,0.000027138754,0.0012014642,0.0014265116,0.0000029283633,0.9783823,0.000024882449,0.009702721,0.00022304172],"about_ca_topic_score_codex":0.0000744035,"about_ca_topic_score_gemma":0.00024232129,"teacher_disagreement_score":0.13127445,"about_ca_system_score_codex":0.0000118503485,"about_ca_system_score_gemma":0.000058074776,"threshold_uncertainty_score":0.9997427},"labels":[],"label_agreement":null},{"id":"W3160082735","doi":"10.1016/j.htct.2021.01.014","title":"Cardiac iron overload evaluation in thalassaemic patients using T2* magnetic resonance imaging following chelation therapy: a multicentre cross-sectional study","year":2021,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"Ministério da Saúde","keywords":"Siderosis; Chelation therapy; Medicine; Deferiprone; Magnetic resonance imaging; Deferasirox; Ferritin; Thalassemia; Gastroenterology; Internal medicine; Hemosiderosis; Pancreas; Radiology","score_opus":0.015978324741816513,"score_gpt":0.2889536065804877,"score_spread":0.27297528183867115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160082735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95763457,0.04032907,0.000016631988,0.000084994914,0.00042896433,0.0011710189,0.0000034189368,0.000029636336,0.000301705],"genre_scores_gemma":[0.99269444,0.006853863,0.00008715627,0.00018300745,0.000020119895,0.000035111003,0.00003985401,0.000026492318,0.000059945898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981356,0.0003195062,0.00041232884,0.00047431167,0.0003875908,0.00027062462],"domain_scores_gemma":[0.99948394,0.00006346695,0.00006263148,0.00018316606,0.00013658185,0.00007020048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041936644,0.00020175896,0.00035638557,0.00011625549,0.00019313896,0.000029651166,0.000037320977,0.00019095979,0.00022029354],"category_scores_gemma":[0.000020089687,0.0001791342,0.00013599911,0.0002708272,0.00005007378,0.000105718726,0.000011774278,0.00028370786,0.0000037130746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046903675,0.0010201618,0.95470166,0.000023245158,0.00001891229,0.000044129287,0.002460301,0.000043617074,0.018566491,0.0000031945656,0.0000037062002,0.022645554],"study_design_scores_gemma":[0.019481797,0.0002130748,0.9690332,0.000078403435,0.000052918702,0.00003199819,0.0015879705,0.007268831,0.0018153704,0.000029033807,0.00022518473,0.00018222131],"about_ca_topic_score_codex":0.000121110475,"about_ca_topic_score_gemma":0.000028429222,"teacher_disagreement_score":0.035059888,"about_ca_system_score_codex":0.00008363875,"about_ca_system_score_gemma":0.00012279778,"threshold_uncertainty_score":0.73048806},"labels":[],"label_agreement":null},{"id":"W3205153815","doi":"10.1016/j.htct.2021.10.040","title":"LONG-TERM SAFETY AND EFFICACY OF DEFERIPRONE FOR THE TREATMENT OF CHRONICALLY TRANSFUSED, IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS","year":2021,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Deferiprone; Medicine; Neutropenia; Internal medicine; Nausea; Adverse effect; Vomiting; Gastroenterology; Ferritin; Deferasirox; Anemia; Deferoxamine; Surgery; Thalassemia; Chemotherapy","score_opus":0.009885080925204846,"score_gpt":0.23826674799525135,"score_spread":0.2283816670700465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205153815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97906286,0.017948916,0.00082266197,0.0006098253,0.00003941033,0.00130909,0.000042405434,0.000013960121,0.00015087354],"genre_scores_gemma":[0.9194696,0.0797495,0.0001292287,0.00020563744,0.000008851668,0.000031098913,0.00003686804,0.000029117215,0.00034008228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903065,0.000051186224,0.0003125659,0.00028828668,0.00012343835,0.00019385912],"domain_scores_gemma":[0.9992648,0.00021821355,0.000071787654,0.00024480373,0.00007043591,0.00012996185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004585538,0.00019835845,0.00049521297,0.00002947199,0.00009987204,0.0000042038578,0.000040412124,0.00014171631,0.00030076312],"category_scores_gemma":[0.000003233666,0.00010037349,0.00012063689,0.00010256946,0.00026191954,0.000019095685,0.0000034999316,0.00007696698,4.9317384e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22352017,0.037440997,0.4477428,0.005253727,0.0013093862,0.00022677587,0.016565813,0.00006722946,0.060836032,0.0004386455,0.000105340114,0.2064931],"study_design_scores_gemma":[0.26946902,0.023212388,0.4438285,0.00071135827,0.0024451064,0.0001418271,0.0016898881,0.00021235833,0.24408337,0.000035476754,0.013335658,0.0008350373],"about_ca_topic_score_codex":0.000018285755,"about_ca_topic_score_gemma":0.00004632218,"teacher_disagreement_score":0.20565806,"about_ca_system_score_codex":0.000012954097,"about_ca_system_score_gemma":0.00013397765,"threshold_uncertainty_score":0.4093112},"labels":[],"label_agreement":null},{"id":"W3208635967","doi":"10.1016/j.htct.2021.10.331","title":"EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135), A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA","year":2021,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Institute of Cancer Research; McGill University Health Centre; University of Calgary","funders":"","keywords":"Medicine; Cytokine release syndrome; Common Terminology Criteria for Adverse Events; Adverse effect; Multiple myeloma; Neutropenia; Internal medicine; Gastroenterology; Oncology; Toxicity; Chimeric antigen receptor; Immunology; Immunotherapy; Cancer","score_opus":0.014867424124680827,"score_gpt":0.2713815356584001,"score_spread":0.2565141115337193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208635967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382734,0.0034682455,0.0001552612,0.0003411021,0.00007759455,0.0011760703,0.000016096856,0.000036189245,0.0009020814],"genre_scores_gemma":[0.9652419,0.033032894,0.0004978055,0.00015843581,0.000019063102,0.000015873862,0.00017317774,0.000051233248,0.00080963364],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99788845,0.00025847592,0.0005317077,0.0005846795,0.0003758429,0.00036081907],"domain_scores_gemma":[0.99878037,0.00032115277,0.00011590718,0.00042659225,0.00019612722,0.00015987385],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024850617,0.00028395702,0.00074735493,0.00026077728,0.00011946508,0.000018127006,0.00008543296,0.00029559262,0.0015618991],"category_scores_gemma":[0.000021416852,0.00020625177,0.000073440984,0.00047980584,0.00023914747,0.000098289864,0.000024245475,0.00042690968,0.000004847299],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067554265,0.0030269353,0.25332126,0.00044698507,0.00010302392,0.00027637545,0.0024624814,0.0000015736224,0.64068645,0.00004134764,0.00007163975,0.032007672],"study_design_scores_gemma":[0.078011,0.0029948528,0.59652245,0.000382405,0.000043440417,0.00017313889,0.0008103923,0.00013321007,0.3110132,0.00001744095,0.00950253,0.0003959662],"about_ca_topic_score_codex":0.00004807178,"about_ca_topic_score_gemma":0.00013703798,"teacher_disagreement_score":0.3432012,"about_ca_system_score_codex":0.00003315217,"about_ca_system_score_gemma":0.00016898586,"threshold_uncertainty_score":0.9993508},"labels":[],"label_agreement":null},{"id":"W3210829182","doi":"10.1016/j.htct.2021.10.384","title":"HEMOPHILIA C: A RARE CASE REPORT IN WOMAN","year":2021,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"","keywords":"Medicine; Partial thromboplastin time; Pediatrics; Coagulation Disorder; Coagulation; Surgery; Fresh frozen plasma; Coagulopathy; Hemarthrosis; Platelet; Internal medicine","score_opus":0.026924491513223014,"score_gpt":0.3063080231368891,"score_spread":0.2793835316236661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210829182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819743,0.0058694184,0.000021523607,0.0052721086,0.000063638094,0.00031034445,0.0000015280236,0.000035199246,0.006451922],"genre_scores_gemma":[0.9845969,0.008512869,0.00027232277,0.0006278367,0.000025396566,0.00003159566,0.000028306225,0.00001815241,0.005886609],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9989062,0.00008636955,0.0002538836,0.00036031124,0.00013390862,0.0002593534],"domain_scores_gemma":[0.9994414,0.00005758032,0.000020750509,0.0002683891,0.00005600998,0.00015589951],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015188595,0.00013919991,0.0003751354,0.00011192114,0.000090576235,0.000007655481,0.00002383643,0.0001757927,0.0010318737],"category_scores_gemma":[0.000010726335,0.0001047771,0.000082697195,0.00023125157,0.00008528613,0.000027749098,0.000011834584,0.00022977403,0.000014758886],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004646039,0.0009407146,0.0896955,0.00015669892,0.000041432795,0.8624436,0.0012062727,1.10311085e-7,0.03462501,0.0002783099,0.00033488875,0.009812818],"study_design_scores_gemma":[0.011032596,0.00041828802,0.006502044,0.000113223134,0.000029639044,0.7102058,0.0013685842,0.000058663612,0.25407988,0.0003159118,0.01564608,0.00022926772],"about_ca_topic_score_codex":0.000046416677,"about_ca_topic_score_gemma":0.00012365467,"teacher_disagreement_score":0.21945488,"about_ca_system_score_codex":0.000016511152,"about_ca_system_score_gemma":0.00012002073,"threshold_uncertainty_score":0.9998813},"labels":[],"label_agreement":null},{"id":"W3212910239","doi":"10.1016/j.htct.2021.10.1047","title":"INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA","year":2021,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Hazard ratio; Exacerbation; Placebo; Platelet; Refractory (planetary science); Randomized controlled trial; Surgery; Confidence interval; Pathology","score_opus":0.02822739829833527,"score_gpt":0.28412392809804915,"score_spread":0.2558965297997139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212910239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97917527,0.018862978,0.000029782228,0.00063510716,0.00013673239,0.00083948084,0.00021383056,0.00004478894,0.0000620414],"genre_scores_gemma":[0.99547726,0.0034736295,0.000041618947,0.0002640058,0.000006024768,0.000047764108,0.0005981037,0.000021101396,0.00007048045],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980894,0.0005316486,0.00042561957,0.0005785339,0.00006534157,0.00030947887],"domain_scores_gemma":[0.9987041,0.000640981,0.000118333366,0.00038529263,0.00011623766,0.000035096586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001369179,0.00030582256,0.0006759379,0.000055760975,0.0002773794,0.000024958617,0.00014152678,0.00013118169,0.00040544398],"category_scores_gemma":[0.00002495811,0.0001681147,0.00004077877,0.0002099556,0.00050353934,0.00007912825,0.000037738846,0.00018054846,0.000010316786],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19180085,0.04190747,0.23839387,0.00037319254,0.008250222,0.000899214,0.08194142,0.000013697223,0.3306758,0.0013550803,0.0073550013,0.09703419],"study_design_scores_gemma":[0.6051296,0.0073923296,0.16943313,0.001143283,0.00063679984,0.00033578038,0.025923496,0.000020535215,0.17902063,0.0003017829,0.009281602,0.0013810352],"about_ca_topic_score_codex":0.000109888824,"about_ca_topic_score_gemma":0.00057799625,"teacher_disagreement_score":0.41332874,"about_ca_system_score_codex":0.000020699008,"about_ca_system_score_gemma":0.00008403518,"threshold_uncertainty_score":0.6855518},"labels":[],"label_agreement":null},{"id":"W3212994588","doi":"10.1016/j.htct.2021.09.002","title":"Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia","year":2021,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Chimeric antigen receptor; Cytokine release syndrome; Medicine; CD19; Hematology; Lymphoblastic Leukemia; CAR T-cell therapy; Cell therapy; Oncology; Leukemia; T cell; Internal medicine; Immunology; Disease; Acute lymphocytic leukemia; Cancer research; Antigen; Cell; Immune system; Biology","score_opus":0.015864145573632197,"score_gpt":0.2614555756327584,"score_spread":0.2455914300591262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212994588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914517,0.002165834,0.0014169215,0.000713107,0.00024162978,0.0023658639,0.00010638043,0.00016163783,0.0013769517],"genre_scores_gemma":[0.9800261,0.009523473,0.002962177,0.0034440032,0.0000760736,0.00023734692,0.0002082726,0.00019568391,0.0033268563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99572515,0.00039642723,0.00072111713,0.0012588735,0.00068459526,0.0012138413],"domain_scores_gemma":[0.9971703,0.0007508282,0.00018545211,0.0008236217,0.00050963735,0.0005601586],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031075245,0.00077064685,0.0013986336,0.00025614124,0.0005506749,0.00007379937,0.00026846188,0.0007605376,0.0012719043],"category_scores_gemma":[0.000019142411,0.00061401597,0.00041961193,0.00038680868,0.00042069383,0.000044958542,0.000046046345,0.0006441396,0.000015793214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019243263,0.0038922317,0.022543114,0.0003666892,0.00080993917,0.00072254456,0.0022339048,0.000029158751,0.93628454,0.00026215127,0.0011773121,0.012435173],"study_design_scores_gemma":[0.045385797,0.007465551,0.0061920113,0.00015478524,0.00020140217,0.0004981991,0.00023899491,0.00086231163,0.9336301,0.00024440815,0.00430077,0.0008256428],"about_ca_topic_score_codex":0.000032568758,"about_ca_topic_score_gemma":0.000015566711,"teacher_disagreement_score":0.026142532,"about_ca_system_score_codex":0.00024075467,"about_ca_system_score_gemma":0.000829947,"threshold_uncertainty_score":0.99964106},"labels":[],"label_agreement":null},{"id":"W4200216722","doi":"10.1016/j.htct.2021.11.011","title":"The tale of two organs: allogeneic hematopoietic stem cell transplantation following liver transplantation in a myelofibrosis patient","year":2021,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Windsor Regional Hospital; Western University","funders":"","keywords":"Myelofibrosis; Transplantation; Stem cell; Medicine; Hematopoietic stem cell transplantation; Haematopoiesis; Biology; Pathology; Surgery; Bone marrow; Cell biology","score_opus":0.011388322681602538,"score_gpt":0.24325754438128386,"score_spread":0.23186922169968133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200216722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830066,0.0147338975,0.0004978837,0.00048820407,0.000097161515,0.00061535276,0.000012275958,0.000019763445,0.0005288423],"genre_scores_gemma":[0.88224524,0.11700012,0.0002809471,0.00023310867,0.0000063667444,0.000104314415,0.000043194468,0.00002063531,0.000066097964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985297,0.00020524328,0.0004668036,0.00034664577,0.00021583725,0.00023580025],"domain_scores_gemma":[0.99932057,0.00027531598,0.00008128697,0.00018022853,0.00006166987,0.00008091527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013010358,0.0002157597,0.00045699356,0.0000788829,0.00015863267,0.000014620966,0.000045342756,0.00012321174,0.00010652394],"category_scores_gemma":[0.0000011971867,0.00015057193,0.00016434863,0.00021768776,0.000067312634,0.00005193387,0.000004155906,0.00013161828,0.0000046250316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031720942,0.003837795,0.21905755,0.0023440334,0.0003414792,0.004761609,0.059676953,0.00004304153,0.65425295,0.0020577016,0.000044888373,0.05040992],"study_design_scores_gemma":[0.007723261,0.0005392437,0.012340412,0.0002456536,0.00017871626,0.00078710774,0.0016106422,0.000047354595,0.9760796,0.00009290716,0.00019516007,0.00015998335],"about_ca_topic_score_codex":0.000050242143,"about_ca_topic_score_gemma":0.00030961985,"teacher_disagreement_score":0.32182664,"about_ca_system_score_codex":0.000021594005,"about_ca_system_score_gemma":0.000085838365,"threshold_uncertainty_score":0.6140145},"labels":[],"label_agreement":null},{"id":"W4306254512","doi":"10.1016/j.htct.2022.09.222","title":"LEUCEMIA LINFOCÍTICA CRÔNICA (LLC) ASSOCIADA A NEOPLASIAS HEMATOLÓGICAS (NH): FENÔMENOS RELACIONADOS OU NÃO? DISCUSSÃO BASEADA NO RELATO DE DOIS CASOS","year":2022,"lang":"pt","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Surgery","score_opus":0.019508094493702083,"score_gpt":0.2801900983176913,"score_spread":0.2606820038239892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306254512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94831693,0.032462843,0.00052368746,0.0056549255,0.0012306996,0.0033983174,0.00024168221,0.0002758013,0.00789511],"genre_scores_gemma":[0.93892735,0.028790409,0.0003584813,0.0030672718,0.00023163731,0.0005999803,0.00015018461,0.0003019262,0.027572772],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906444,0.0017401867,0.0017041252,0.0018189165,0.0018271751,0.0022652273],"domain_scores_gemma":[0.99466985,0.0017674277,0.00045759918,0.0015122716,0.00027170553,0.0013211648],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019117701,0.0011137768,0.0022194511,0.0004753831,0.0018707691,0.00009653098,0.00081651425,0.0011673529,0.0135583645],"category_scores_gemma":[0.00019652623,0.0009932133,0.0006640316,0.0011168242,0.00068853085,0.0001716151,0.00042056348,0.0031803523,0.00040451178],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.11270055,0.03668708,0.06803932,0.015935866,0.010686532,0.08583974,0.17562708,0.00095828157,0.14070784,0.03403076,0.29541954,0.023367401],"study_design_scores_gemma":[0.2717526,0.013337135,0.0011586233,0.001979018,0.002513227,0.064170994,0.034701012,0.11166388,0.03830432,0.0009831758,0.45346776,0.005968249],"about_ca_topic_score_codex":0.001715951,"about_ca_topic_score_gemma":0.0002615636,"teacher_disagreement_score":0.15905206,"about_ca_system_score_codex":0.0075114234,"about_ca_system_score_gemma":0.01248768,"threshold_uncertainty_score":0.9994287},"labels":[],"label_agreement":null},{"id":"W4306254535","doi":"10.1016/j.htct.2022.09.020","title":"LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON–TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA","year":2022,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Pyruvate kinase; Thalassemia; Anemia; Gastroenterology; Glycolysis; Metabolism","score_opus":0.008207481707575523,"score_gpt":0.23420248695477883,"score_spread":0.2259950052472033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306254535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361193,0.0025513489,0.000044929744,0.0019157846,0.0001247461,0.0013662288,0.000014156066,0.000027304646,0.00034359278],"genre_scores_gemma":[0.9777851,0.021316934,0.000038041857,0.0004973037,0.0000076121164,0.000058320642,0.000013572261,0.00003601792,0.00024708165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983351,0.00017888112,0.00041814215,0.00044555136,0.00029959844,0.00032269044],"domain_scores_gemma":[0.99930674,0.00011561699,0.00009792118,0.00030932546,0.00003497826,0.00013543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021327435,0.0002751079,0.000603402,0.0001246961,0.00030222282,0.000006813697,0.00013252032,0.00019123725,0.00064579607],"category_scores_gemma":[0.0000042820984,0.00015472491,0.00009175427,0.00035900096,0.00025576763,0.000046105037,0.000046491226,0.0006019909,8.7730996e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07236649,0.004214011,0.67979795,0.0011926746,0.0003336219,0.0010288783,0.014784928,0.000038910955,0.1825428,0.00018108268,0.00014114441,0.04337749],"study_design_scores_gemma":[0.11779173,0.0067060543,0.6456573,0.0015413442,0.00035708785,0.0023900254,0.0075794053,0.00019583944,0.21463802,0.000047338726,0.002157537,0.00093832635],"about_ca_topic_score_codex":0.00013861997,"about_ca_topic_score_gemma":0.00021591224,"teacher_disagreement_score":0.04542524,"about_ca_system_score_codex":0.000029027831,"about_ca_system_score_gemma":0.00012649068,"threshold_uncertainty_score":0.7071014},"labels":[],"label_agreement":null},{"id":"W4306254671","doi":"10.1016/j.htct.2022.09.050","title":"PERSPECTIVAS DOS MÉDICOS BRASILEIROS SOBRE A DOENÇA FALCIFORME E SEU TRATAMENTO: RESULTADOS DA PESQUISA DE CONHECIMENTO, PERSPECTIVAS E EXPERIÊNCIAS EM SAÚDE DA DOENÇA FALCIFORME (SICKLE CELL HEALTH AWARENESS, PERSPECTIVES AND EXPERIENCES, SHAPE)","year":2022,"lang":"pt","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Humanities; Philosophy","score_opus":0.024376584079016612,"score_gpt":0.29854620786043,"score_spread":0.2741696237814134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306254671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84081405,0.1482628,0.0005973921,0.0029500914,0.0007402888,0.0033021953,0.0003171682,0.00026332558,0.0027526875],"genre_scores_gemma":[0.9291999,0.06332579,0.00022707997,0.0033253,0.00025604293,0.0010874979,0.00016909458,0.00022487578,0.0021844623],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99065495,0.0013774591,0.0015179497,0.002759859,0.0013340181,0.0023557858],"domain_scores_gemma":[0.99637955,0.00030896266,0.00065441546,0.0011133889,0.00022528297,0.0013184223],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0012684221,0.001609528,0.0025499885,0.00073140766,0.0033651765,0.00035206592,0.00071555236,0.00063207274,0.008332393],"category_scores_gemma":[0.000037220263,0.0014816454,0.0005920102,0.0010183946,0.0013904364,0.0005162354,0.00026797716,0.0017596007,0.000027999004],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076352297,0.0068738423,0.016760292,0.0012176645,0.00027163382,0.00036154786,0.9206974,0.000011646744,0.028724223,0.0034647156,0.0051223557,0.008859483],"study_design_scores_gemma":[0.02439831,0.0035571288,0.004985523,0.00017442988,0.0002282249,0.001052125,0.9418079,0.00086360006,0.007574947,0.0001220757,0.01369883,0.0015368725],"about_ca_topic_score_codex":0.0021133646,"about_ca_topic_score_gemma":0.00022568837,"teacher_disagreement_score":0.0883858,"about_ca_system_score_codex":0.0006685293,"about_ca_system_score_gemma":0.0017248569,"threshold_uncertainty_score":0.99966526},"labels":[],"label_agreement":null},{"id":"W4306319940","doi":"10.1016/j.htct.2022.09.415","title":"A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM): INITIAL SAFETY RESULTS FOR MAGNETISMM-3","year":2022,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Cytokine release syndrome; Internal medicine; Adverse effect; Gastroenterology; Regimen; Multiple myeloma; Cohort; Refractory (planetary science); Antibody; Oncology; Immunology; Cancer; Immunotherapy; Chimeric antigen receptor","score_opus":0.022036251958436188,"score_gpt":0.307113675771095,"score_spread":0.2850774238126588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306319940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917379,0.0008981949,0.0003467184,0.0003895461,0.00028719116,0.0045363917,0.00028975037,0.00004602116,0.0014682985],"genre_scores_gemma":[0.9921859,0.0052924897,0.00035300673,0.00017286562,0.00006454025,0.00025069542,0.00097628403,0.000068097535,0.00063611305],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99693567,0.00042696318,0.00089466164,0.00067677785,0.0005942075,0.00047169894],"domain_scores_gemma":[0.9985909,0.00040010212,0.00024094354,0.0004584503,0.0001575616,0.00015205432],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000722335,0.00032361137,0.00083249074,0.0004838299,0.00027991194,0.000015285137,0.00017605812,0.00023214566,0.0011700154],"category_scores_gemma":[0.000023110037,0.000276304,0.00017880186,0.00047884998,0.00021510094,0.0001034364,0.000034425026,0.00057401933,0.0000027038843],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74124044,0.010250799,0.002261509,0.00019313,0.000059456303,0.000082598795,0.002616507,0.0000050999906,0.20987768,0.000036089074,0.00036904775,0.03300761],"study_design_scores_gemma":[0.80665183,0.04128265,0.0038996597,0.00008488343,0.000050070797,0.000078648365,0.0010184454,0.0005647356,0.094932966,0.00004540429,0.050961524,0.00042920423],"about_ca_topic_score_codex":0.00010794786,"about_ca_topic_score_gemma":0.00008941552,"teacher_disagreement_score":0.11494472,"about_ca_system_score_codex":0.000079546684,"about_ca_system_score_gemma":0.00020626573,"threshold_uncertainty_score":0.9999689},"labels":[],"label_agreement":null},{"id":"W4306320268","doi":"10.1016/j.htct.2022.09.087","title":"AVALIAÇÃO COGNITIVA DE PACIENTES ADULTOS COM DOENÇAS FALCIFORMES: O IMPACTO DAS CONDIÇÕES SOCIOECONÔMICAS E CORRELAÇÕES COM ACHADOS DE NEUROIMAGEM","year":2022,"lang":"pt","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.021970955145604237,"score_gpt":0.30270648473291717,"score_spread":0.28073552958731296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306320268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95818037,0.023805719,0.0026044394,0.009124881,0.0011342478,0.0025961788,0.00065822894,0.00028269168,0.0016132217],"genre_scores_gemma":[0.93822485,0.047279634,0.000030702882,0.009739518,0.000085489584,0.00038395,0.00017936296,0.00015270791,0.00392376],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99456644,0.0012416348,0.00093021535,0.0010972045,0.0006033144,0.001561173],"domain_scores_gemma":[0.99725646,0.0010751816,0.00038910462,0.00045058134,0.00023024196,0.0005984389],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007925937,0.00093041663,0.0015533289,0.00041958375,0.0019032244,0.00007557619,0.00033728764,0.0004245023,0.0065232413],"category_scores_gemma":[0.00007054748,0.00087620347,0.00050003506,0.00047216134,0.0010854255,0.00015761695,0.00019593957,0.001845945,0.000095821255],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021511374,0.00694421,0.6300231,0.0020637203,0.003228786,0.002773454,0.13623132,0.000029737057,0.12244459,0.00045778684,0.04802823,0.026263662],"study_design_scores_gemma":[0.12809466,0.028815204,0.07786426,0.002509972,0.005119359,0.01980883,0.48027998,0.01076557,0.1801639,0.0015871354,0.05916429,0.005826831],"about_ca_topic_score_codex":0.00022678534,"about_ca_topic_score_gemma":0.000057081976,"teacher_disagreement_score":0.5521589,"about_ca_system_score_codex":0.0003281702,"about_ca_system_score_gemma":0.00051254337,"threshold_uncertainty_score":0.99939615},"labels":[],"label_agreement":null},{"id":"W4310553285","doi":"10.1016/j.htct.2022.11.001","title":"Correlation between ABO blood type, susceptibility to SARS-CoV-2 infection and COVID-19 disease severity: A systematic review","year":2022,"lang":"en","type":"review","venue":"Hematology Transfusion and Cell Therapy","topic":"Blood groups and transfusion","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Universidade Estadual do Ceará; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"ABO blood group system; Checklist; Medicine; Disease; Internal medicine; Scopus; Blood type (non-human); MEDLINE; Biology","score_opus":0.06392654193586891,"score_gpt":0.3523925520906883,"score_spread":0.28846601015481943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310553285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054404824,0.9854347,0.0005378286,0.00046549336,0.00017507619,0.0076429048,0.0000570261,0.00013671156,0.00010975911],"genre_scores_gemma":[0.00079919334,0.99529135,0.00003221194,0.0027956527,0.00004333809,0.0004923488,0.00038188926,0.0000717396,0.00009228755],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99646246,0.0008871565,0.0010818833,0.00091983617,0.00033686933,0.0003117844],"domain_scores_gemma":[0.99813825,0.00040324577,0.00026574926,0.000621147,0.000060062983,0.00051153405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009007289,0.00059368194,0.0035354886,0.00027965722,0.00035285417,0.000024424386,0.00008970243,0.00040928347,0.00036725643],"category_scores_gemma":[0.00011506152,0.00045231273,0.0004384539,0.00065560726,0.00010211609,0.00006058929,0.000041917538,0.0006826396,0.000019256657],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018509474,0.0004871694,0.0015098787,0.9634223,0.00032480623,0.00012385061,0.00024897233,5.565398e-8,0.000017603252,0.00006699542,0.00020766837,0.033405606],"study_design_scores_gemma":[0.0043961,0.0014884854,0.00032674774,0.18681535,0.022732705,0.0022562428,0.00003357076,0.000012498924,0.000030452877,0.00014173209,0.7806776,0.0010885115],"about_ca_topic_score_codex":0.00014029784,"about_ca_topic_score_gemma":0.000061904044,"teacher_disagreement_score":0.78046995,"about_ca_system_score_codex":0.00007048029,"about_ca_system_score_gemma":0.00035811786,"threshold_uncertainty_score":0.9997929},"labels":[],"label_agreement":null},{"id":"W4321601974","doi":"10.1016/j.htct.2023.01.007","title":"Translation and cultural adaptation of the Health Utilities Preschool to Brazilian Portuguese","year":2023,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Sample (material); Portuguese; Quality of life (healthcare); Population; Public health; Medicine; Health care; Preference; Adaptation (eye); Estimation; Gerontology; Environmental health; Psychology; Nursing; Political science; Statistics","score_opus":0.2595697986747551,"score_gpt":0.3940849636300094,"score_spread":0.13451516495525428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321601974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9469067,0.0122780735,0.0011411902,0.03795508,0.00020934151,0.0008017609,0.00006521344,0.00004091144,0.0006017508],"genre_scores_gemma":[0.98335475,0.010882792,0.00041176323,0.0048905956,0.000026556158,0.000056217457,0.000017372568,0.000014283802,0.00034566838],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9979707,0.00023717002,0.0012595034,0.00028215497,0.00005539204,0.00019505306],"domain_scores_gemma":[0.9991065,0.00022773232,0.0003541865,0.00018127581,0.000025288326,0.000104973005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025862423,0.00010939071,0.00048146953,0.00014449724,0.00018406469,0.000014118705,0.00008473609,0.0000916892,0.000089219044],"category_scores_gemma":[0.00005693216,0.00009777821,0.00005781889,0.00019320968,0.00007675182,0.00014188941,0.000009063946,0.00008646816,0.00003904976],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086451747,0.0005768444,0.2387425,0.0041889553,0.00023388193,0.0000026938799,0.3450175,0.0005931096,0.0020618776,0.20432648,0.0333593,0.17003234],"study_design_scores_gemma":[0.008868174,0.0012671789,0.689448,0.0004253414,0.000016183121,0.00005384159,0.06059084,0.030739496,0.0013493873,0.027295906,0.17886741,0.0010782414],"about_ca_topic_score_codex":0.00068802055,"about_ca_topic_score_gemma":0.00031228247,"teacher_disagreement_score":0.4507055,"about_ca_system_score_codex":0.000022092652,"about_ca_system_score_gemma":0.00005183252,"threshold_uncertainty_score":0.39872795},"labels":[],"label_agreement":null},{"id":"W4386189225","doi":"10.1016/j.htct.2023.07.005","title":"Extramedullary haematopoiesis in patients with thalassemia: a cross-sectional description of its prevalence, clinical features and survival","year":2023,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"Ministério da Saúde","keywords":"Medicine; Hazard ratio; Internal medicine; Confidence interval; Extramedullary hematopoiesis; Cross-sectional study; Thalassemia; Cohort; Gastroenterology; Magnetic resonance imaging; Pediatrics; Pathology; Radiology; Haematopoiesis","score_opus":0.0336181875670144,"score_gpt":0.3139517174565897,"score_spread":0.2803335298895753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386189225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584025,0.0029536341,0.000011267065,0.00019007376,0.000108271684,0.00060926203,0.000014516701,0.000030226354,0.00024248807],"genre_scores_gemma":[0.9586222,0.040871907,0.00009294001,0.00009285285,0.000013642453,0.00006128685,0.000029813265,0.000014119853,0.00020124216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987948,0.00012558152,0.00035774065,0.00034261085,0.00020648721,0.0001727667],"domain_scores_gemma":[0.9994083,0.00022927595,0.00006982729,0.00011014182,0.00009274424,0.00008971572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026194935,0.00016000391,0.00046046154,0.0001385246,0.00007351929,0.000012447901,0.000030408162,0.00021804747,0.00011030182],"category_scores_gemma":[0.000014749405,0.00010860038,0.000059350812,0.00018459486,0.00016649933,0.00006703204,0.000010359134,0.00018796428,0.0000030403553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018239921,0.0008480067,0.9950504,0.00036488162,0.000061728926,0.000034210592,0.0003128186,8.376884e-7,0.00027831536,0.00026779794,0.000068311485,0.00088871503],"study_design_scores_gemma":[0.0080865575,0.0010407331,0.9868824,0.0001497011,0.000025374951,0.000060284605,0.00006152432,0.000016972455,0.0034735962,0.000047954003,0.00006442716,0.00009049945],"about_ca_topic_score_codex":0.000008130746,"about_ca_topic_score_gemma":0.000040415227,"teacher_disagreement_score":0.037918273,"about_ca_system_score_codex":0.000011050948,"about_ca_system_score_gemma":0.00004396926,"threshold_uncertainty_score":0.44285953},"labels":[],"label_agreement":null},{"id":"W4387746991","doi":"10.1016/j.htct.2023.09.095","title":"LEVANTAMENTO DOS ÓBITOS DE ANEMIA APLÁSTICA NA INFÂNCIA NO HEMORIO: ESTUDO RETROSPECTIVO","year":2023,"lang":"pt","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Anemia; Gynecology; Internal medicine","score_opus":0.013856371139286075,"score_gpt":0.28328697668198277,"score_spread":0.2694306055426967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387746991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776147,0.013537366,0.0001527807,0.002393731,0.0010172302,0.00096467667,0.00005478919,0.00028316883,0.0039815377],"genre_scores_gemma":[0.9237814,0.06381792,0.000112649795,0.002905941,0.0003566071,0.00007108373,0.00008947225,0.00007603467,0.008788881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99676424,0.0001431933,0.00066944055,0.00085534906,0.00042239012,0.0011453982],"domain_scores_gemma":[0.9982105,0.0002532994,0.00013265773,0.0005143876,0.00012556558,0.00076360133],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005048802,0.00053807447,0.00091926276,0.00017987036,0.00042985065,0.000032595948,0.00021123317,0.00083019276,0.001594692],"category_scores_gemma":[0.00004122224,0.00047248363,0.00019300182,0.00058293785,0.00029739493,0.0000538043,0.00005006742,0.00090111425,0.000659915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008668268,0.0017315808,0.12845148,0.00814762,0.00020232062,0.0026717577,0.0066100513,6.46752e-7,0.7861334,0.00036773196,0.02435147,0.032663666],"study_design_scores_gemma":[0.028849887,0.0045152013,0.030472415,0.0014468479,0.00035292056,0.0029973544,0.005720999,0.0012656562,0.88059807,0.00043165244,0.04162735,0.0017216554],"about_ca_topic_score_codex":0.00017272613,"about_ca_topic_score_gemma":0.00003240969,"teacher_disagreement_score":0.09797906,"about_ca_system_score_codex":0.00011548818,"about_ca_system_score_gemma":0.00040776137,"threshold_uncertainty_score":0.99977267},"labels":[],"label_agreement":null},{"id":"W4387748826","doi":"10.1016/j.htct.2023.09.517","title":"OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION","year":2023,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); McGill University Health Centre","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Internal medicine; Calicheamicin; Refractory (planetary science); Adverse effect; Transplantation; Salvage therapy; Gastroenterology; Surgery; Oncology; Chemotherapy; Myeloid leukemia","score_opus":0.009324414593363263,"score_gpt":0.23411395898418505,"score_spread":0.2247895443908218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387748826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734885,0.00023710473,0.00014702778,0.000212507,0.00007302572,0.00143302,0.000013119149,0.00011580669,0.00041953727],"genre_scores_gemma":[0.99592984,0.002765719,0.00022408563,0.0002123894,0.000007514426,0.00010813595,0.000048391128,0.000055890563,0.0006480384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831045,0.00005186123,0.00038519234,0.00056520244,0.00025594555,0.0004313674],"domain_scores_gemma":[0.99935794,0.00015128028,0.00007858228,0.00017704154,0.000044729128,0.00019045723],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011802292,0.00034514247,0.00064329506,0.00034842148,0.00011318105,0.00001959902,0.00007205196,0.00017656336,0.000042324984],"category_scores_gemma":[0.0000016675233,0.00026359456,0.000049684935,0.00041691473,0.00006065557,0.000094301,0.0000145947515,0.00019229822,0.00002764871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028618248,0.0005831903,0.95792603,0.0011152789,0.000092647635,0.00015645461,0.0157261,0.000018678578,0.01665289,0.000023254246,0.00005545271,0.00478818],"study_design_scores_gemma":[0.08098558,0.00346613,0.743636,0.0010539896,0.00043502825,0.00025591764,0.0024134524,0.00057687867,0.16615474,0.00006423163,0.00010409898,0.000853952],"about_ca_topic_score_codex":0.000042863965,"about_ca_topic_score_gemma":0.00003260371,"teacher_disagreement_score":0.21429005,"about_ca_system_score_codex":0.0002344089,"about_ca_system_score_gemma":0.00016169442,"threshold_uncertainty_score":0.99998164},"labels":[],"label_agreement":null},{"id":"W4396768109","doi":"10.1016/j.htct.2024.04.067","title":"PROGNOSTIC EVALUATION OF THE NUTRITIONAL PROGNOSTIC INDEX IN PATIENTS WITH NON-METASTATIC RECTAL CANCER","year":2024,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Colorectal cancer; Oncology; Internal medicine; Cancer; Index (typography); Computer science","score_opus":0.011291425136674459,"score_gpt":0.28615576815424787,"score_spread":0.2748643430175734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396768109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944855,0.002675362,0.00033484056,0.0012510765,0.00012631305,0.00093313353,0.0000031114134,0.000012775095,0.00017786483],"genre_scores_gemma":[0.99890226,0.0006294375,0.00011642095,0.00018992434,0.000013674771,0.000102625934,0.000011504218,0.000013663038,0.000020469517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990891,0.00010351333,0.00018052208,0.00018007873,0.00032954273,0.000117200456],"domain_scores_gemma":[0.99965745,0.00011713913,0.000030510975,0.0000750124,0.00007978722,0.000040127823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003031007,0.00009253067,0.00019627565,0.000092460126,0.00003877991,0.000007667864,0.00003700303,0.0000450891,0.00015888616],"category_scores_gemma":[0.000029379407,0.00005222312,0.000036512924,0.00021790515,0.00011884271,0.000027975533,0.0000049097202,0.0002538032,7.1586965e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000271824,0.0004119611,0.96087015,0.00033279098,0.00004235257,0.00000839156,0.000594293,0.000034738696,0.0008220035,0.00007317437,0.000043860076,0.03649446],"study_design_scores_gemma":[0.0068658325,0.00031634246,0.95746964,0.0011397612,0.00015054157,0.000047905032,0.00007507753,0.032557633,0.0007908163,0.00036734596,0.00013372315,0.000085402105],"about_ca_topic_score_codex":0.000036614867,"about_ca_topic_score_gemma":0.000019656598,"teacher_disagreement_score":0.036409058,"about_ca_system_score_codex":0.000018898507,"about_ca_system_score_gemma":0.00016218753,"threshold_uncertainty_score":0.2129597},"labels":[],"label_agreement":null},{"id":"W4402334252","doi":"10.1016/j.htct.2024.05.014","title":"Comprehensive health status and health-related quality of life of children at diagnosis of high-risk neuroblastoma: a multicentric pilot study","year":2024,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital; McMaster University","funders":"","keywords":"Medicine; Quality of life (healthcare); Medical diagnosis; Disease; Neuroblastoma; Pediatrics; Limiting; Health related quality of life; Gerontology; Environmental health; Pathology; Nursing","score_opus":0.046734016751651376,"score_gpt":0.33243553006690724,"score_spread":0.28570151331525584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402334252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688995,0.028355608,0.00000961002,0.0008279007,0.000054768607,0.0017171857,0.00009230491,0.000034933728,0.000008211233],"genre_scores_gemma":[0.914284,0.085454695,0.000042869757,0.00013259852,0.0000036446413,0.000028626624,0.00001675175,0.000022512644,0.0000143321095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975342,0.0006552102,0.00081892696,0.00039966125,0.00027593208,0.00031605552],"domain_scores_gemma":[0.99864984,0.0004639432,0.00024387414,0.00022616776,0.000076416,0.00033976967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002586545,0.00019843242,0.0010828013,0.00024412644,0.000094096366,0.0000036733502,0.000045846864,0.00005228218,0.00008595757],"category_scores_gemma":[0.0000152436605,0.00014953774,0.000076467935,0.0003175075,0.00022142059,0.000028051256,0.000032026237,0.00022485993,0.0000018643854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062647043,0.007886679,0.9650422,0.0019206676,0.00065325585,0.000034386998,0.00332656,0.0000028621848,0.0046984097,0.000091394926,0.00011414683,0.009964786],"study_design_scores_gemma":[0.01631361,0.02318953,0.94817096,0.00014864802,0.00005453786,0.000048401354,0.0002995385,0.00003390693,0.011604014,0.000031563333,0.00001852444,0.00008677154],"about_ca_topic_score_codex":0.0076495744,"about_ca_topic_score_gemma":0.00039918398,"teacher_disagreement_score":0.057099085,"about_ca_system_score_codex":0.00002464495,"about_ca_system_score_gemma":0.00017430287,"threshold_uncertainty_score":0.9989586},"labels":[],"label_agreement":null},{"id":"W4403553947","doi":"10.1016/j.htct.2024.09.259","title":"GLOBAL COMPARATIVE ANTITHROMBIN-FIELD STUDY: IMPACT OF LABORATORY ASSAY VARIABILITY ON THE ASSESSMENT OF ANTITHROMBIN ACTIVITY MEASUREMENT","year":2024,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision BioLogic (Canada)","funders":"","keywords":"Antithrombin; Medicine; Internal medicine; Heparin","score_opus":0.060437727218038965,"score_gpt":0.4010302038011226,"score_spread":0.3405924765830836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403553947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99055105,0.0004034914,0.0017888144,0.0022060445,0.00014169059,0.0012203588,0.000028343322,0.000032997905,0.0036272234],"genre_scores_gemma":[0.99873245,0.00094969495,0.000047016572,0.00020851506,0.000012618404,0.000030755826,0.0000016195755,0.000009366321,0.000007948594],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976131,0.0009769306,0.00030433244,0.00033603588,0.00058577134,0.00018384993],"domain_scores_gemma":[0.998719,0.00048537194,0.00006448402,0.00036931437,0.00027889083,0.0000829836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002119376,0.00018487101,0.000661916,0.00008144215,0.00008403668,0.00001417576,0.000092532566,0.00012651943,0.00048103364],"category_scores_gemma":[0.000029348044,0.000107812906,0.00018742091,0.00044110193,0.00023036083,0.000045099776,0.000020339248,0.00033994578,0.0000027431465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024448736,0.008286498,0.4445665,0.00039720378,0.0026147517,0.000052211235,0.0024421765,0.000015826403,0.5246096,0.0056179683,0.0059000994,0.0030523085],"study_design_scores_gemma":[0.0045796405,0.011828455,0.7042599,0.00021936187,0.00020408549,0.000042817217,0.0013313584,0.0012424772,0.27501425,0.0004088883,0.0006273283,0.0002414459],"about_ca_topic_score_codex":0.00034199614,"about_ca_topic_score_gemma":0.000018553821,"teacher_disagreement_score":0.2596934,"about_ca_system_score_codex":0.000116369694,"about_ca_system_score_gemma":0.00045112267,"threshold_uncertainty_score":0.5266981},"labels":[],"label_agreement":null},{"id":"W4403554275","doi":"10.1016/j.htct.2024.09.1131","title":"THE RELATION BETWEEN IMMUNE THROMBOCYTOPENIA AND CEREBRAL SINUS VENOUS THROMBOSIS IN PEDIATRIC POPULATION. A CASE SERIES","year":2024,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Immune thrombocytopenia; Venous thrombosis; Thrombosis; Cerebral venous sinus thrombosis; Population; Cardiology; Pediatrics; Internal medicine; Platelet","score_opus":0.018886953388139574,"score_gpt":0.2694590321001423,"score_spread":0.25057207871200277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403554275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773657,0.018355835,0.000034646455,0.0028189681,0.00017574937,0.0006574703,0.0000073561328,0.00011173861,0.00047254947],"genre_scores_gemma":[0.9767392,0.022766137,0.0001353221,0.00007789789,0.00008150443,0.00002884606,0.000023076604,0.00004118282,0.000106802945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985556,0.00013699831,0.00044485545,0.00040628156,0.00014881477,0.00030744934],"domain_scores_gemma":[0.9993651,0.00023167612,0.00004964923,0.00023022809,0.000028059158,0.00009527079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003100095,0.0002331267,0.0005870482,0.00017922815,0.00040399353,0.00007109669,0.000054344233,0.00024693753,0.00008593593],"category_scores_gemma":[0.000009325456,0.0001642031,0.000085332904,0.0003804508,0.00012918259,0.00017403364,0.000023512595,0.0003764824,0.000011140486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054237543,0.0005097242,0.9449112,0.00083880406,0.00020602957,0.0018864606,0.011928651,0.000002161099,0.0062901103,0.004827066,0.0001269209,0.027930513],"study_design_scores_gemma":[0.0024452696,0.0009940447,0.97771233,0.00011583258,0.00025161693,0.012568443,0.0009143083,0.00013800671,0.0020460964,0.0020580927,0.00045642367,0.00029954247],"about_ca_topic_score_codex":0.00052251486,"about_ca_topic_score_gemma":0.00048848934,"teacher_disagreement_score":0.03280114,"about_ca_system_score_codex":0.000045727626,"about_ca_system_score_gemma":0.000055878038,"threshold_uncertainty_score":0.6696008},"labels":[],"label_agreement":null},{"id":"W4403554281","doi":"10.1016/j.htct.2024.09.1075","title":"ACQUIRED HEMOPHILIA A IN A 3-YEAR-OLD PEDIATRIC PATIENT: A CASE REPORT OF RARE AND POTENTIALLY FATAL BLEEDING DISORDER","year":2024,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pediatrics","score_opus":0.014704056948510933,"score_gpt":0.27342653131726397,"score_spread":0.258722474368753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403554281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98262334,0.015108872,0.000038622176,0.0010717248,0.000089443085,0.000537141,0.000006041978,0.00003735877,0.00048746262],"genre_scores_gemma":[0.9823632,0.01681382,0.00015374129,0.00004252358,0.000028970788,0.000026507172,0.000016307742,0.000021632586,0.00053326413],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99884856,0.000047208378,0.0003430314,0.00036346592,0.00016795559,0.00022981],"domain_scores_gemma":[0.9995989,0.00007349579,0.000030054907,0.00014370658,0.000037289796,0.00011655759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001603319,0.00015795839,0.00037356073,0.00029235284,0.00006393342,0.000014564662,0.0000272979,0.00016774726,0.00017331068],"category_scores_gemma":[0.000008226347,0.00011357486,0.00008054908,0.00030548382,0.000101836195,0.000056118104,0.000019487234,0.00015056775,0.0000022171203],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027241274,0.0019254527,0.48809844,0.0036617275,0.00023547908,0.3711366,0.014883062,0.0000010584935,0.053809818,0.0010033611,0.00023012688,0.06229074],"study_design_scores_gemma":[0.056816187,0.009684173,0.029485721,0.001890211,0.00096983276,0.72781396,0.013413775,0.0029675243,0.14482118,0.001969517,0.008273608,0.0018943193],"about_ca_topic_score_codex":0.00009444689,"about_ca_topic_score_gemma":0.00003702471,"teacher_disagreement_score":0.45861274,"about_ca_system_score_codex":0.000009908743,"about_ca_system_score_gemma":0.00006750543,"threshold_uncertainty_score":0.46314484},"labels":[],"label_agreement":null},{"id":"W4403554472","doi":"10.1016/j.htct.2024.09.1094","title":"ESTUDO FAMILIAL REVELA O PRIMEIRO CASO DE HEMOGLOBINA OTTAWA EM COERANÇA DE ALFA TALASSEMIA NO BRASIL","year":2024,"lang":"pt","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Humanities; Gynecology; Art","score_opus":0.009770036704035633,"score_gpt":0.26273512959853607,"score_spread":0.2529650928945004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403554472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8579407,0.12889418,0.0018540698,0.0015460127,0.0018041547,0.0009463985,0.00004673336,0.00022644129,0.006741333],"genre_scores_gemma":[0.8682388,0.11475076,0.0005254451,0.004262499,0.00037980697,0.00006877291,0.00005744486,0.00015441749,0.011562081],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99627405,0.00045753177,0.0007527504,0.001020213,0.0003757629,0.0011196788],"domain_scores_gemma":[0.99842995,0.00031370574,0.0000875117,0.0005306345,0.00009262019,0.0005455509],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077712775,0.00071549433,0.0011409835,0.00026440714,0.0003701675,0.00009321161,0.00025142956,0.000951847,0.0019396389],"category_scores_gemma":[0.0000365611,0.00062435155,0.0003712478,0.0004124249,0.0003575431,0.000120962344,0.000035221157,0.0009844765,0.00036485083],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005975714,0.004052937,0.10571059,0.0097572915,0.00068852375,0.004995712,0.06211267,0.000009884302,0.5516572,0.00877736,0.15596609,0.09029605],"study_design_scores_gemma":[0.05698501,0.004664238,0.07784185,0.0032893645,0.0028105066,0.010292687,0.021275347,0.0042947815,0.21616141,0.0014257826,0.59649664,0.0044623623],"about_ca_topic_score_codex":0.00036235555,"about_ca_topic_score_gemma":0.00016618225,"teacher_disagreement_score":0.44053057,"about_ca_system_score_codex":0.000075977594,"about_ca_system_score_gemma":0.0007057,"threshold_uncertainty_score":0.9996208},"labels":[],"label_agreement":null},{"id":"W4403554476","doi":"10.1016/j.htct.2024.09.975","title":"PROPHYLAXIS FOR INHERITED DEFICIENCY OF FACTOR X (PROTECT-X): A SYSTEMATIC REVIEW","year":2024,"lang":"en","type":"review","venue":"Hematology Transfusion and Cell Therapy","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.07235114842213759,"score_gpt":0.3739265813118142,"score_spread":0.30157543288967664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403554476","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018387516,0.9850176,0.00004252733,0.00013982147,0.00008105535,0.0142492885,0.000052254032,0.00005459839,0.00017899202],"genre_scores_gemma":[0.000093389724,0.9965561,0.00008871675,0.000063076,0.00001836325,0.0019224215,0.000054512464,0.000069675036,0.0011337528],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99771243,0.00024387625,0.0009956055,0.0005015028,0.00024943775,0.00029716137],"domain_scores_gemma":[0.9989495,0.00022235981,0.0001829621,0.00041082394,0.00010584835,0.00012847983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003439202,0.00045319725,0.0042225877,0.0002957916,0.000069006346,0.000010345843,0.00013175736,0.00050417933,0.00016569885],"category_scores_gemma":[0.000039257313,0.00023270125,0.00088613044,0.00045980874,0.0001251068,0.0000159656,0.000015994163,0.00040214646,0.00003131162],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042854736,0.00024922666,0.0000014087676,0.91327083,0.00022041857,0.000036483983,0.00011290876,2.76153e-10,0.00005905396,0.00005601124,0.00008767299,0.085863136],"study_design_scores_gemma":[0.0013793897,0.0022153407,3.0002212e-7,0.87931013,0.003999426,0.0007979223,0.000032165437,0.000002795833,0.00030029195,0.0000424337,0.111599304,0.00032051836],"about_ca_topic_score_codex":0.0000038719227,"about_ca_topic_score_gemma":9.13213e-7,"teacher_disagreement_score":0.11151163,"about_ca_system_score_codex":0.000029366318,"about_ca_system_score_gemma":0.00027197812,"threshold_uncertainty_score":0.9489281},"labels":[],"label_agreement":null},{"id":"W4403568317","doi":"10.1016/j.htct.2024.09.1403","title":"TRANSFUSÃO PRÉ-HOSPITALAR NO SAMU AÉREO – AVALIAÇÃO DA SOBREVIDA DOS PACIENTES","year":2024,"lang":"pt","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nortel (Canada)","funders":"","keywords":"Medicine","score_opus":0.02024427168563705,"score_gpt":0.2537984434279122,"score_spread":0.23355417174227514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403568317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54609656,0.25244895,0.0062775966,0.055133507,0.016231053,0.00507898,0.00014872407,0.0021938218,0.11639079],"genre_scores_gemma":[0.86280495,0.1205482,0.00011751961,0.0060756723,0.00062624126,0.00013090581,0.00010620472,0.00019545869,0.009394876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955062,0.0001947759,0.0011046045,0.0015747717,0.00070001255,0.0009196289],"domain_scores_gemma":[0.998335,0.00041991155,0.0002210451,0.00055917096,0.00031611655,0.00014874047],"candidate_categories":["metaepi_narrow","scholarly_communication","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010466297,0.0009722691,0.0010465938,0.0007673451,0.0008634957,0.0014814812,0.00048418395,0.0006945974,0.015811406],"category_scores_gemma":[0.000029839499,0.0008411112,0.00057294953,0.0012174993,0.00037753733,0.002129403,0.000060566144,0.0010299541,0.002748159],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006190416,0.012507761,0.023352413,0.033454783,0.004139033,0.002871929,0.023517516,0.000020289921,0.110122874,0.25000644,0.10917041,0.42464614],"study_design_scores_gemma":[0.005856852,0.00030987858,0.0006241578,0.00087092235,0.00079168414,0.00019037296,0.002093175,0.0026480672,0.0064232126,0.001419033,0.97735107,0.001421561],"about_ca_topic_score_codex":0.0001955822,"about_ca_topic_score_gemma":0.00010865335,"teacher_disagreement_score":0.8681807,"about_ca_system_score_codex":0.00002036764,"about_ca_system_score_gemma":0.000119773125,"threshold_uncertainty_score":0.99955505},"labels":[],"label_agreement":null},{"id":"W4403568488","doi":"10.1016/j.htct.2024.09.944","title":"GENETIC AND NON-GENETIC DETERMINANTS OF SUCCESSFUL IMMUNE TOLERANCE INDUCTION IN PEOPLE WITH SEVERE HEMOPHILIA A","year":2024,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Centre Hospitalier Universitaire Sainte-Justine; McMaster University; Queen's University; Hospital for Sick Children","funders":"","keywords":"Medicine; Immune system; Immune tolerance; Immunology; Genetic diagnosis; Computational biology; Genetics; Gene; Biology","score_opus":0.01107195582513129,"score_gpt":0.2659603653752765,"score_spread":0.25488840955014525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403568488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98385316,0.014916229,0.000030964708,0.00039094294,0.00005716514,0.0005206932,0.0000019355389,0.000018451405,0.00021045048],"genre_scores_gemma":[0.9720172,0.027343726,0.0002442997,0.00003127894,0.000016423872,0.00003740384,0.0000022933998,0.000019729474,0.00028763144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907786,0.000042540698,0.00024223817,0.00030475017,0.00013137664,0.00020125981],"domain_scores_gemma":[0.99968404,0.000045460907,0.000022252992,0.0001440689,0.000028489632,0.00007568586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007886508,0.00015231501,0.00041262826,0.00017801691,0.000048099588,0.000010583472,0.000038409573,0.00013945001,0.00010594999],"category_scores_gemma":[0.0000012398676,0.000101614016,0.000037685524,0.00026488464,0.00013379414,0.000040279778,0.000008742416,0.00017071077,0.0000029450064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010383859,0.00029979937,0.8693703,0.001087333,0.00003709137,0.00043183987,0.0026241557,0.0000025494285,0.065301985,0.0000076087244,0.0000073589395,0.05979162],"study_design_scores_gemma":[0.0050785625,0.0012828764,0.8718022,0.00059212284,0.000042434553,0.0023988753,0.0003329001,0.0011813452,0.116909906,0.00008070937,0.00012789448,0.00017018654],"about_ca_topic_score_codex":0.0001805723,"about_ca_topic_score_gemma":0.0002463645,"teacher_disagreement_score":0.059621435,"about_ca_system_score_codex":0.000010685496,"about_ca_system_score_gemma":0.00007515445,"threshold_uncertainty_score":0.41436994},"labels":[],"label_agreement":null},{"id":"W4403568737","doi":"10.1016/j.htct.2024.09.947","title":"LARGE DELETIONS IN THE F8 GENE PREDICT IMMUNE TOLERANCE INDUCTION FAILURE IN PEOPLE WITH SEVERE HEMOPHILIA A","year":2024,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University; Hospital for Sick Children","funders":"","keywords":"Medicine; Gene; Immune system; Immune tolerance; Immunology; Genetics; Biology","score_opus":0.012184683614887637,"score_gpt":0.26105104339647456,"score_spread":0.24886635978158692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403568737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786946,0.007731698,0.00011059514,0.01187005,0.000059821938,0.00080035784,0.0000063619086,0.000044647833,0.00068187946],"genre_scores_gemma":[0.9869774,0.011979384,0.00008634758,0.00024333128,0.00003821319,0.00014489244,0.000037578437,0.000018586368,0.00047424875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887955,0.00012336466,0.00021022029,0.0003075198,0.00019100493,0.00028830898],"domain_scores_gemma":[0.99963975,0.00007516459,0.000013107875,0.00019471472,0.000023919087,0.000053347863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028562822,0.00015782246,0.00029790233,0.00019943416,0.00010545304,0.000020526937,0.00006761722,0.00017153047,0.00023890585],"category_scores_gemma":[0.0000023769687,0.00008756664,0.000057200064,0.0005731033,0.000073066716,0.0000658078,0.0000068802883,0.00046161795,0.000011896076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062050526,0.006395476,0.6467062,0.0019400282,0.00033582264,0.0043991404,0.07799004,0.00004081787,0.22377096,0.004313437,0.0017582909,0.026144737],"study_design_scores_gemma":[0.06724938,0.0071257497,0.6527787,0.0031613645,0.000292433,0.025292203,0.023940032,0.006523279,0.14522325,0.0023381715,0.064450346,0.001625095],"about_ca_topic_score_codex":0.000058301124,"about_ca_topic_score_gemma":0.00084436877,"teacher_disagreement_score":0.07854771,"about_ca_system_score_codex":0.00002541279,"about_ca_system_score_gemma":0.00009130267,"threshold_uncertainty_score":0.3570864},"labels":[],"label_agreement":null},{"id":"W4403568812","doi":"10.1016/j.htct.2024.09.936","title":"AVALIAÇÃO DE PARÂMETROS DO TESTE DE GERAÇÃO DE TROMBINA EM GESTANTES COM PRÉ-ECLÂMPSIA: REVISÃO SISTEMÁTICA","year":2024,"lang":"pt","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Maternal and Neonatal Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Humanities; Gynecology; Art","score_opus":0.0396876162477359,"score_gpt":0.35525084156051695,"score_spread":0.315563225312781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403568812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.832897,0.14814164,0.0019028987,0.01320002,0.0010840086,0.0015095017,0.00016813526,0.00034128843,0.00075547723],"genre_scores_gemma":[0.8406515,0.14660938,0.00023240113,0.0037152201,0.0001631587,0.0001994565,0.00002492696,0.00013498086,0.008268985],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934934,0.002210737,0.0011953155,0.0009858881,0.00035432796,0.001760349],"domain_scores_gemma":[0.9968372,0.001452115,0.00019128574,0.00054817897,0.00010935863,0.0008618542],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017405433,0.0006838496,0.0012059404,0.0002798464,0.0011677387,0.00011021526,0.00037933182,0.0012836667,0.0027326767],"category_scores_gemma":[0.000032630393,0.00057127175,0.0003333547,0.00044742753,0.00022330675,0.00013034005,0.000070294,0.0020552264,0.00028101035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077947024,0.003443513,0.25877947,0.11904178,0.0009106032,0.008424911,0.26732075,0.000004064465,0.058778077,0.050883126,0.022024225,0.20259479],"study_design_scores_gemma":[0.03974057,0.013907829,0.08090819,0.076916896,0.0019839068,0.017999863,0.1113775,0.022529822,0.100629844,0.073401466,0.4516405,0.008963629],"about_ca_topic_score_codex":0.00067758537,"about_ca_topic_score_gemma":0.00025583865,"teacher_disagreement_score":0.42961627,"about_ca_system_score_codex":0.00027489758,"about_ca_system_score_gemma":0.00081979873,"threshold_uncertainty_score":0.9996739},"labels":[],"label_agreement":null},{"id":"W4403568813","doi":"10.1016/j.htct.2024.09.839","title":"ANTITUMORAL POTENTIAL OF GREEN MICROALGAE EXTRACTS IN CHRONIC MYELOID LEUKEMIA (CML) IN VITRO MODEL","year":2024,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Cancer and biochemical research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cambrian College; Laurentian University","funders":"","keywords":"Myeloid leukemia; Medicine; In vitro; Chronic myeloid leukaemia; Cancer research; Pharmacology; Traditional medicine; Biology; Biochemistry","score_opus":0.011167841778430982,"score_gpt":0.27159225384670693,"score_spread":0.26042441206827593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403568813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773569,0.021449396,0.00047265174,0.00017597311,0.000045759713,0.00017497044,0.0000156692,0.000007143984,0.00030154898],"genre_scores_gemma":[0.97364587,0.025818853,0.0000924083,0.0000791941,0.000036087014,0.000015762378,0.00004598656,0.000015544467,0.00025030872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901295,0.000041428095,0.00023152486,0.00035527526,0.00009552424,0.0002632763],"domain_scores_gemma":[0.9997612,0.000010693575,0.00001653328,0.00013666105,0.000018233912,0.000056646146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001301839,0.00013277815,0.0002188825,0.000111345624,0.000019644167,0.000009464163,0.00011401424,0.00022443972,0.000041645166],"category_scores_gemma":[0.0000020590348,0.00011560668,0.00007912776,0.00013620332,0.00012841035,0.0000047968383,0.000023321309,0.00020268398,0.000001729453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091217033,0.00006586668,0.0001909011,0.00015463494,0.000009439214,0.00003791006,0.00009548829,0.00004228991,0.9811886,0.000037267397,0.00005877698,0.017206647],"study_design_scores_gemma":[0.0014755665,0.00015639403,0.00042957216,0.000039051476,0.000003279827,0.000045666824,0.00002905952,0.0040445896,0.9929308,0.00017062518,0.00055214425,0.00012324404],"about_ca_topic_score_codex":0.0003428253,"about_ca_topic_score_gemma":0.00031497382,"teacher_disagreement_score":0.017083403,"about_ca_system_score_codex":0.00003734581,"about_ca_system_score_gemma":0.0002854336,"threshold_uncertainty_score":0.47143033},"labels":[],"label_agreement":null},{"id":"W4403568842","doi":"10.1016/j.htct.2024.09.865","title":"LONG-TERM FOLLOW-UP FROM THE PHASE 1/2 MAJESTEC-1 TRIAL OF TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS BY LINES OF THERAPIES","year":2024,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Subgroup analysis; Refractory (planetary science); Multiple myeloma; Internal medicine; Term (time); Oncology; Meta-analysis","score_opus":0.015667412912132736,"score_gpt":0.2839526485226636,"score_spread":0.26828523561053086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403568842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850141,0.013111368,0.00023666165,0.00021621783,0.000095881325,0.0011188458,0.00014646431,0.000027048764,0.00003341627],"genre_scores_gemma":[0.99180824,0.007568393,0.00007251022,0.000041401363,0.000017650162,0.0000648476,0.00029136357,0.000026181635,0.00010939481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984012,0.0001850424,0.00046525156,0.00037539267,0.000340721,0.0002323523],"domain_scores_gemma":[0.9988503,0.00054297806,0.00009264184,0.00034382698,0.00007964145,0.00009065445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001739416,0.00023225865,0.0007379177,0.00023773039,0.000060468963,0.000014055441,0.0001091508,0.00016472077,0.00024264077],"category_scores_gemma":[0.000015359221,0.0001262943,0.00020915346,0.0005039014,0.00024085098,0.00006584151,0.000011799213,0.00023159193,0.0000016774989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11597108,0.0039727637,0.8303033,0.00013664545,0.0015623529,0.000060522012,0.0017093488,2.4160738e-7,0.013386103,0.000009888407,0.000046218545,0.032841545],"study_design_scores_gemma":[0.42416778,0.0070612156,0.51887876,0.0003526932,0.0008290058,0.0000053597096,0.00039916002,0.00024448844,0.047424525,0.000035371664,0.0003416661,0.00025994782],"about_ca_topic_score_codex":0.00038971673,"about_ca_topic_score_gemma":0.00051696796,"teacher_disagreement_score":0.31142452,"about_ca_system_score_codex":0.000017174954,"about_ca_system_score_gemma":0.00006116956,"threshold_uncertainty_score":0.5150132},"labels":[],"label_agreement":null},{"id":"W4403568979","doi":"10.1016/j.htct.2024.09.742","title":"LUSPATERCEPT UTILIZATION PATTERNS IN LOWER-RISK MYELODYSPLASTIC SYNDROMES: FINDINGS FROM A MULTINATIONAL MEDICAL RECORD REVIEW STUDY","year":2024,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multinational corporation; Myelodysplastic syndromes; Family medicine; Internal medicine; Finance","score_opus":0.03426642712876994,"score_gpt":0.3318220713860433,"score_spread":0.2975556442572734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403568979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97447145,0.018468564,0.0027722062,0.0026624845,0.00024460006,0.0011643438,0.000021217807,0.000088932065,0.00010621512],"genre_scores_gemma":[0.7661298,0.2326609,0.000091326845,0.0007201172,0.000030439893,0.00010474719,0.000075637676,0.000030430643,0.00015661411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978783,0.00032165303,0.0004506974,0.00057070603,0.00050216966,0.0002764358],"domain_scores_gemma":[0.9990291,0.0004986341,0.0000318561,0.0002059777,0.000052069678,0.00018235293],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006305389,0.00022277207,0.0005593742,0.00026682424,0.00007480506,0.000020922294,0.0001216021,0.00023773169,0.0068122945],"category_scores_gemma":[0.00008771971,0.00016833124,0.000085086285,0.000362967,0.00008085035,0.000069409754,0.000029769044,0.0006748069,0.00008206315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015688351,0.0029298114,0.69751316,0.0038876291,0.0003191344,0.0059029977,0.0070002344,9.4804346e-7,0.0024200787,0.00008310273,0.0028806538,0.27549344],"study_design_scores_gemma":[0.060369153,0.010128684,0.7884299,0.04582657,0.0009558276,0.004414423,0.004925882,0.042784348,0.0048591774,0.000915577,0.03421848,0.002171989],"about_ca_topic_score_codex":0.00033014888,"about_ca_topic_score_gemma":0.00035839446,"teacher_disagreement_score":0.27332145,"about_ca_system_score_codex":0.00007668655,"about_ca_system_score_gemma":0.0001998252,"threshold_uncertainty_score":0.9940956},"labels":[],"label_agreement":null},{"id":"W4403569308","doi":"10.1016/j.htct.2024.09.055","title":"ENERGIZE: A GLOBAL PHASE 3 STUDY OF MITAPIVAT DEMONSTRATING EFFICACY AND SAFETY IN ADULTS WITH ALPHA- OR BETA-NON–TRANSFUSION-DEPENDENT THALASSEMIA","year":2024,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; BETA (programming language); Alpha (finance); Beta thalassemia; Thalassemia; Intensive care medicine; Internal medicine; Surgery","score_opus":0.008989807767580151,"score_gpt":0.27283641352261756,"score_spread":0.26384660575503743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403569308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867982,0.009803272,0.0002356259,0.00068918517,0.00009419927,0.001375376,0.000010354043,0.00006323126,0.00093055575],"genre_scores_gemma":[0.96710986,0.032512527,0.00013260478,0.00010259054,0.000012312853,0.00003299036,0.000009040915,0.000026046571,0.00006204312],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982657,0.000108918546,0.00053866266,0.0005499577,0.0002361393,0.00030063622],"domain_scores_gemma":[0.99941736,0.00014304898,0.000049646256,0.00019174852,0.000037289512,0.00016091969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020830239,0.00029911412,0.0006718199,0.00013072822,0.00011301081,0.000016639051,0.000063893094,0.00026930316,0.00016134602],"category_scores_gemma":[0.0000043242067,0.00018293623,0.00006187604,0.00041102382,0.00016298419,0.000060956147,0.000012951117,0.00035783785,0.0000012408832],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.110170625,0.025046952,0.2602408,0.004650752,0.0014091212,0.008378822,0.066099994,0.00006692127,0.080533236,0.0011164488,0.0001863281,0.4421],"study_design_scores_gemma":[0.5793754,0.07495856,0.09295262,0.013612426,0.001980299,0.014133398,0.1386338,0.0072497036,0.07156482,0.00022280712,0.0025151358,0.0028010572],"about_ca_topic_score_codex":0.00031920092,"about_ca_topic_score_gemma":0.00059092254,"teacher_disagreement_score":0.46920475,"about_ca_system_score_codex":0.000020100735,"about_ca_system_score_gemma":0.0001327538,"threshold_uncertainty_score":0.7459923},"labels":[],"label_agreement":null},{"id":"W4403569520","doi":"10.1016/j.htct.2024.09.057","title":"IMPROVEMENTS IN FATIGUE AND 6-MINUTE WALK TEST IN ADULTS WITH ALPHA- OR BETA-NON–TRANSFUSION-DEPENDENT THALASSEMIA: THE PHASE 3 ENERGIZE TRIAL OF MITAPIVAT","year":2024,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Alpha (finance); BETA (programming language); Beta thalassemia; Test (biology); Thalassemia; Physical therapy; Internal medicine; Surgery","score_opus":0.012125431506100657,"score_gpt":0.267642548107346,"score_spread":0.2555171166012453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403569520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871737,0.008068085,0.000093905786,0.0022238684,0.00016631396,0.001618108,0.000012098533,0.00002788983,0.0006160818],"genre_scores_gemma":[0.9186994,0.08059353,0.00005381231,0.00024240618,0.000018470853,0.0001033539,0.000012451713,0.000028881655,0.0002477155],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99843144,0.00008035676,0.00052046916,0.00044690326,0.0002228871,0.00029791426],"domain_scores_gemma":[0.99933547,0.0002728612,0.000051354833,0.00021169281,0.000028473225,0.00010017424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028750158,0.00026745608,0.0005777022,0.0002022218,0.000070250535,0.000015055205,0.00008181537,0.0003073429,0.0001649184],"category_scores_gemma":[0.0000073222627,0.00013742918,0.00007499021,0.00034853662,0.00020543451,0.000062114916,0.000012984181,0.00046118212,0.0000010507969],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28977144,0.012062514,0.044239294,0.0038357489,0.0005242238,0.0033019423,0.03677066,0.0000107521855,0.29841724,0.00044177967,0.00049146614,0.31013295],"study_design_scores_gemma":[0.7186363,0.0238744,0.004608986,0.0048175026,0.00039897213,0.0012612302,0.013620623,0.002659242,0.22572137,0.00026667208,0.0032000958,0.00093463133],"about_ca_topic_score_codex":0.00052042137,"about_ca_topic_score_gemma":0.0007980852,"teacher_disagreement_score":0.42886484,"about_ca_system_score_codex":0.00001668792,"about_ca_system_score_gemma":0.00014199801,"threshold_uncertainty_score":0.5604199},"labels":[],"label_agreement":null},{"id":"W4405746714","doi":"10.1016/j.htct.2024.11.006","title":"RICHTER TRANSFORMATION OF CLL DISEASE: A CASE REPORT WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT","year":2024,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Glycogen Storage Diseases and Myoclonus","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Disease; Central nervous system; Pathology; Internal medicine","score_opus":0.010638155355526013,"score_gpt":0.24048822429296682,"score_spread":0.2298500689374408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405746714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98096424,0.0133851655,0.0034820857,0.00046958306,0.00015905433,0.0006779989,0.00002281934,0.00010566334,0.0007334032],"genre_scores_gemma":[0.99765825,0.0017716916,0.00009449701,0.00016809741,0.000029112396,0.000048599028,0.00005567235,0.000022473088,0.00015162391],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99898916,0.000037108974,0.00032912652,0.00026485475,0.00017282838,0.00020692896],"domain_scores_gemma":[0.9994573,0.000019740917,0.00004106778,0.00018928322,0.000051843086,0.00024073619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009216242,0.00016454786,0.000320459,0.00009682422,0.00006589578,0.00001324119,0.000025565496,0.0000756123,0.00011191595],"category_scores_gemma":[7.7163e-7,0.00010891818,0.00012292106,0.00012997634,0.000057334928,0.0000597663,0.0000030275066,0.000100041114,0.0000027812825],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051616253,0.0008394666,0.0042277486,0.0077393977,0.0003948892,0.93858325,0.007217449,0.000008942242,0.009829305,0.0064067584,0.0003748037,0.019216344],"study_design_scores_gemma":[0.01204564,0.002333112,0.0041271276,0.0021030216,0.0016770462,0.89094603,0.008139511,0.0042439653,0.04626081,0.00009039498,0.027307106,0.0007262586],"about_ca_topic_score_codex":0.00008468953,"about_ca_topic_score_gemma":0.0000179053,"teacher_disagreement_score":0.04763726,"about_ca_system_score_codex":0.000022063832,"about_ca_system_score_gemma":0.00010586737,"threshold_uncertainty_score":0.44415545},"labels":[],"label_agreement":null},{"id":"W4411236837","doi":"10.1016/j.htct.2025.103847","title":"Multi-cohort gene expression model enhances prognostic stratification in diffuse large B-cell lymphoma","year":2025,"lang":"en","type":"letter","venue":"Hematology Transfusion and Cell Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stratification (seeds); Lymphoma; Risk stratification; Diffuse large B-cell lymphoma; Cohort; Prognostic model; Oncology; Expression (computer science); Internal medicine; Computational biology; Cancer research; Overall survival; Biology; Computer science","score_opus":0.017259435767511176,"score_gpt":0.26237200953283735,"score_spread":0.24511257376532616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411236837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9387282,0.01303533,0.0017094242,0.041949198,0.00024274267,0.0028722966,0.000071337585,0.000116456,0.0012749926],"genre_scores_gemma":[0.77049714,0.096638836,0.0040503447,0.12105272,0.00017629792,0.0017225296,0.0014965136,0.00009744679,0.004268145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99759674,0.00015668463,0.0005859222,0.00091270707,0.00027616322,0.00047178066],"domain_scores_gemma":[0.9990312,0.00016896005,0.0001484858,0.00049174397,0.00006431586,0.00009529919],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013509888,0.0005223933,0.00095559435,0.00028610817,0.00014164716,0.000029036724,0.00013062563,0.0011129581,0.00007501087],"category_scores_gemma":[0.0000057457937,0.0003956651,0.00018771809,0.00015498229,0.00008012922,0.000054957425,0.00002043019,0.00040927125,0.000012937623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002877326,0.12665544,0.21452346,0.006706663,0.00069157314,0.0054126945,0.0057908646,0.000010936553,0.4200727,0.00019871454,0.19907315,0.017986467],"study_design_scores_gemma":[0.09337476,0.0006484308,0.011253781,0.0013529204,0.00049147283,0.0002015398,0.00018183865,0.004333666,0.8565064,0.00018017602,0.030447232,0.0010278019],"about_ca_topic_score_codex":0.000049767397,"about_ca_topic_score_gemma":0.000034927703,"teacher_disagreement_score":0.4364337,"about_ca_system_score_codex":0.00008010626,"about_ca_system_score_gemma":0.00023569276,"threshold_uncertainty_score":0.9998495},"labels":[],"label_agreement":null},{"id":"W4411328802","doi":"10.1016/j.htct.2025.103861","title":"CD36 as a marker of acute myeloid leukemia prognosis: A systematic review","year":2025,"lang":"en","type":"review","venue":"Hematology Transfusion and Cell Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Medicine; Myeloid leukemia; CD36; Oncology; Internal medicine","score_opus":0.022473494268197558,"score_gpt":0.33281673183745086,"score_spread":0.3103432375692533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411328802","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059425904,0.98490196,0.00003336544,0.00041589962,0.00009688931,0.010725813,0.00003671697,0.00008819491,0.0036417146],"genre_scores_gemma":[0.000008080066,0.9908241,0.00017733827,0.0012895145,0.000023555544,0.002207322,0.00012048607,0.00009192862,0.005257654],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9952737,0.00095479854,0.001874871,0.0008518445,0.0005017507,0.000543049],"domain_scores_gemma":[0.99736995,0.00064452545,0.0005283423,0.0009768934,0.00021553063,0.0002647769],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096770964,0.00080422114,0.008213533,0.00054122513,0.000106473606,0.000016012835,0.0004281766,0.0009383412,0.0006497389],"category_scores_gemma":[0.00008254375,0.00051985314,0.0012383964,0.0009005286,0.00026118886,0.00004465129,0.00007832033,0.0010618132,0.00008350815],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016477844,0.0001776006,0.000005170212,0.9216945,0.0015342012,0.0002588259,0.00008824715,1.26685e-9,0.000026163205,0.00016002948,0.0019162693,0.07397421],"study_design_scores_gemma":[0.0019258359,0.0004408388,8.492001e-7,0.7967577,0.010015082,0.003290705,0.00003533434,0.0000025872496,0.00017788121,0.000025448626,0.18695185,0.0003759015],"about_ca_topic_score_codex":0.00002809469,"about_ca_topic_score_gemma":0.0000021938326,"teacher_disagreement_score":0.18503559,"about_ca_system_score_codex":0.00020320904,"about_ca_system_score_gemma":0.0024036265,"threshold_uncertainty_score":0.9997253},"labels":[],"label_agreement":null},{"id":"W4412746711","doi":"10.1016/j.htct.2025.103958","title":"A dream or reality: Consideration of ‘bloodless’ hematopoietic stem cell transplants for Jehovah’s witness patients","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Dream; Witness; Haematopoiesis; Surgery; Stem cell; Psychotherapist; Law; Psychology","score_opus":0.02809691674729993,"score_gpt":0.2871908636018117,"score_spread":0.25909394685451176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412746711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651092,0.001097433,0.028138554,0.0006972006,0.00023124053,0.0023042522,0.000070681424,0.000078370314,0.0022730432],"genre_scores_gemma":[0.9929537,0.0047248835,0.00062765117,0.000571029,0.000011576939,0.00016985399,0.00011756186,0.00003541661,0.0007883214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980135,0.00013247077,0.00080571923,0.0004936367,0.00023584897,0.00031882402],"domain_scores_gemma":[0.9987336,0.0004674011,0.00015173266,0.00031405708,0.0002099232,0.00012328279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027214937,0.000311461,0.0009039448,0.00022392024,0.00015542694,0.000013669351,0.000088290624,0.00034814616,0.00012460852],"category_scores_gemma":[0.0000046345485,0.00024456636,0.00015998096,0.00024354663,0.00018523904,0.000064075444,0.0000054871234,0.00015546533,0.0000029201506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058947828,0.017858023,0.22168565,0.07333996,0.0013561929,0.0002899479,0.052395366,0.000028830811,0.49399838,0.032612294,0.0025156357,0.04497188],"study_design_scores_gemma":[0.028306376,0.0012189656,0.004053416,0.0010464705,0.0004686907,0.00019245483,0.0014756782,0.00020949535,0.96073264,0.0010722014,0.00086792425,0.00035568292],"about_ca_topic_score_codex":0.000026142003,"about_ca_topic_score_gemma":0.000040964675,"teacher_disagreement_score":0.46673426,"about_ca_system_score_codex":0.000018090237,"about_ca_system_score_gemma":0.0001987737,"threshold_uncertainty_score":0.99731266},"labels":[],"label_agreement":null},{"id":"W4414061553","doi":"10.1016/j.htct.2025.103981","title":"An enigmatic tale of macrophages in bone marrow causing inflammation of the brain: A case report on CNS HLH","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Inflammation; Bone marrow; Granulomatous inflammation; Radiological weapon; Bone Marrow Diseases","score_opus":0.012959104489275692,"score_gpt":0.29686218862350117,"score_spread":0.2839030841342255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414061553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403673,0.0016418642,0.0001430854,0.0019219614,0.000042468626,0.0005517407,0.0000012553824,0.000011702716,0.0016492136],"genre_scores_gemma":[0.99825686,0.0009814284,0.000042795677,0.00020547012,0.0000041691615,0.000018551747,0.000004636341,0.000009332877,0.0004767689],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885017,0.00016885808,0.0005206523,0.00017733796,0.00014410725,0.00013887289],"domain_scores_gemma":[0.99935323,0.00009549464,0.00011270819,0.0003500527,0.000059454644,0.000029066745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040859813,0.00010754516,0.0004048069,0.0002004104,0.00008263451,0.000004261357,0.000047658792,0.00012854951,0.00014257044],"category_scores_gemma":[0.00003216385,0.000074616735,0.00007195044,0.00027097372,0.00018628723,0.00004432047,0.000011254925,0.0001883591,5.455752e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011789468,0.0007229013,0.03255953,0.0012062041,0.000060204948,0.005725936,0.0048974184,0.00001851656,0.92755175,0.0012858148,0.00012771084,0.024665063],"study_design_scores_gemma":[0.0056771776,0.00048178388,0.020402465,0.0004767067,0.0000298046,0.0072792545,0.002201485,0.0008399581,0.9612527,0.00051834714,0.0007186868,0.000121666075],"about_ca_topic_score_codex":0.0001233433,"about_ca_topic_score_gemma":0.00011688003,"teacher_disagreement_score":0.03370091,"about_ca_system_score_codex":0.000011324102,"about_ca_system_score_gemma":0.000117243195,"threshold_uncertainty_score":0.30427822},"labels":[],"label_agreement":null},{"id":"W4415668898","doi":"10.1016/j.htct.2025.105049","title":"ANTÍGENO ERITROCITÁRIO DEA 1 EM CÃES DE DIFERENTES RAÇAS NA CIDADE DE LONDRINA/PR","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Test (biology); Statistical analysis; Significant difference","score_opus":0.008067412539835367,"score_gpt":0.2509414910941221,"score_spread":0.24287407855428675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415668898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700275,0.0117674265,0.012258777,0.0023434074,0.00014786977,0.00046375926,0.0000052001824,0.00013356021,0.0028524701],"genre_scores_gemma":[0.9632264,0.031836838,0.0009484782,0.0028042346,0.000037513244,0.000044134573,0.00001599863,0.000031245745,0.001055189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985128,0.000119713906,0.00032144057,0.0004250672,0.00013410898,0.0004868803],"domain_scores_gemma":[0.99933773,0.00010938727,0.000038768103,0.000266011,0.00005102597,0.00019705798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002038034,0.0002847375,0.0005836252,0.00017626997,0.00025586705,0.000027768963,0.00011093321,0.00034785795,0.00042122754],"category_scores_gemma":[0.000006117105,0.00023145307,0.0001784325,0.00022018557,0.00012866325,0.00004389397,0.000016090788,0.0003752528,0.00000925795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032839736,0.0019689554,0.21585925,0.0008863685,0.00033605122,0.0003662826,0.0068480787,0.000001296609,0.6640772,0.008023635,0.0008621328,0.09748673],"study_design_scores_gemma":[0.016164813,0.0010680627,0.069772966,0.0004339307,0.00034326233,0.0012863567,0.0020324124,0.00025551254,0.885552,0.0032360288,0.019358303,0.00049634423],"about_ca_topic_score_codex":0.00010719279,"about_ca_topic_score_gemma":0.00015966581,"teacher_disagreement_score":0.22147477,"about_ca_system_score_codex":0.000027520035,"about_ca_system_score_gemma":0.00014427613,"threshold_uncertainty_score":0.94383824},"labels":[],"label_agreement":null},{"id":"W4415668960","doi":"10.1016/j.htct.2025.104824","title":"DARATUMUMAB PLUS BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (DVRD) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): SUBGROUP ANALYSIS OF TRANSPLANT- INELIGIBLE (TIE) PATIENTS IN THE PHASE 3 CEPHEUS STUDY","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Multiple myeloma; Clinical endpoint; Daratumumab; Subgroup analysis; Post-hoc analysis; Population; Overall survival; Phases of clinical research; Confidence interval","score_opus":0.012867494538952943,"score_gpt":0.28694795537164447,"score_spread":0.27408046083269155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415668960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587417,0.001041974,0.00017337434,0.00015598118,0.00002817849,0.0025183442,0.000060464892,0.0000150971,0.00013240041],"genre_scores_gemma":[0.99653035,0.0026652103,0.00009778239,0.0002841901,0.0000029655757,0.00016888443,0.00021309196,0.000016880735,0.000020654381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773335,0.0004023847,0.00058034033,0.00052633416,0.00037380066,0.00038377923],"domain_scores_gemma":[0.9987802,0.00054637116,0.00009300415,0.00036184874,0.000101128986,0.00011743274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033325056,0.00030675056,0.0010323199,0.0008505853,0.00011444789,0.000018715129,0.00013601706,0.00012947439,0.000047091926],"category_scores_gemma":[0.000026221143,0.0001898554,0.000100510355,0.0013062102,0.00016869414,0.00007930569,0.000015587662,0.00028815656,5.5992365e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024486758,0.010118702,0.94823223,0.0001036965,0.000670897,0.00015400784,0.0056211953,0.000007973127,0.00019176696,0.0000121395005,0.00001767383,0.010382939],"study_design_scores_gemma":[0.13875322,0.0024205965,0.8553948,0.00008714384,0.00039926506,0.00000277475,0.0009816581,0.00054251676,0.0012115762,0.000009129555,0.000057319645,0.00014002471],"about_ca_topic_score_codex":0.0020162528,"about_ca_topic_score_gemma":0.005827567,"teacher_disagreement_score":0.11426646,"about_ca_system_score_codex":0.00003867547,"about_ca_system_score_gemma":0.00007382718,"threshold_uncertainty_score":0.7742079},"labels":[],"label_agreement":null},{"id":"W4415668966","doi":"10.1016/j.htct.2025.104457","title":"RESULTS FROM VERIFY, A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF RUSFERTIDE FOR THE TREATMENT OF POLYCYTHEMIA VERA","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Phlebotomy; Polycythemia vera; Clinical endpoint; Hematocrit; Placebo; Clinical trial; Randomized controlled trial","score_opus":0.04133502875619269,"score_gpt":0.3419187682989942,"score_spread":0.3005837395428015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415668966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98631525,0.005676622,0.00020224303,0.0014666133,0.00012337153,0.0055931085,0.000064245934,0.000016843564,0.00054172165],"genre_scores_gemma":[0.9842864,0.013914589,0.000101445374,0.00014825586,0.000020607222,0.0011427145,0.000038014507,0.000013297016,0.00033463511],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986857,0.000083251056,0.00059383665,0.00034530746,0.00012663823,0.0001652709],"domain_scores_gemma":[0.9982273,0.0011483226,0.00013090328,0.00035374323,0.00008175306,0.000057969602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013225878,0.00023828639,0.0010110558,0.00010293768,0.00013123523,0.000006654876,0.00006367446,0.00011910461,0.0000834923],"category_scores_gemma":[0.000007716098,0.00012771763,0.00021366175,0.00011625659,0.00008652179,0.000016130882,0.0000051048005,0.00006635217,8.1136596e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9153709,0.025910664,0.007145382,0.000054530603,0.002359327,0.000022118113,0.009769784,0.000005081454,0.019390509,0.00046630765,0.00016159273,0.019343827],"study_design_scores_gemma":[0.63037544,0.009993737,0.00081628567,0.000058445738,0.00073468994,0.000005325201,0.0014902139,0.00017777618,0.35410732,0.00006432608,0.0020942667,0.00008217785],"about_ca_topic_score_codex":0.00042588744,"about_ca_topic_score_gemma":0.00021039006,"teacher_disagreement_score":0.33471683,"about_ca_system_score_codex":0.000022946164,"about_ca_system_score_gemma":0.00008557522,"threshold_uncertainty_score":0.5208174},"labels":[],"label_agreement":null},{"id":"W4415668968","doi":"10.1016/j.htct.2025.104823","title":"DARATUMUMAB + BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (DVRD) VS VRD IN TRANSPLANT-INELIGIBLE (TIE)/TRANSPLANT-DEFERRED (TD) NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): PHASE 3 CEPHEUS TRIAL CYTOGENETIC SUBGROUP ANALYSIS","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Daratumumab; Post-hoc analysis; Subgroup analysis; Overall survival; Multiple myeloma; Dexamethasone; Randomized controlled trial; Post hoc","score_opus":0.016632488741825695,"score_gpt":0.28689884151977596,"score_spread":0.27026635277795025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415668968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97579634,0.018731803,0.0014041879,0.0011310353,0.00022202106,0.0019761634,0.000101997066,0.00009719579,0.0005392407],"genre_scores_gemma":[0.92751646,0.07037503,0.00033936667,0.00096547324,0.0000360126,0.00035690452,0.00024322077,0.000037606867,0.00012991864],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967656,0.00031765684,0.00096185115,0.0010223675,0.0002828604,0.00064966275],"domain_scores_gemma":[0.99825144,0.00075082073,0.0001238969,0.0004962556,0.000060803533,0.000316799],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003452523,0.0006072124,0.001810134,0.00082707574,0.00024403959,0.00005430282,0.00014718925,0.00042699373,0.0002159739],"category_scores_gemma":[0.000015780686,0.00049190095,0.00042258966,0.0009802388,0.00022311902,0.00008745978,0.000014675452,0.00028962316,0.0000052571622],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2620743,0.010732184,0.6387741,0.0005539484,0.0028044751,0.00252031,0.0043654116,0.00002018813,0.034674738,0.00032567044,0.00032022066,0.042834453],"study_design_scores_gemma":[0.72161996,0.0039539146,0.10542676,0.0005042526,0.0039110836,0.00039488016,0.00054279726,0.0015270839,0.15681781,0.00020082104,0.0041862046,0.00091442786],"about_ca_topic_score_codex":0.00092159765,"about_ca_topic_score_gemma":0.0019096003,"teacher_disagreement_score":0.5333473,"about_ca_system_score_codex":0.00006383273,"about_ca_system_score_gemma":0.00015555309,"threshold_uncertainty_score":0.99975324},"labels":[],"label_agreement":null},{"id":"W4415669037","doi":"10.1016/j.htct.2025.104071","title":"ASSOCIAÇÃO ENTRE ANEMIA MATERNA E PREMATURIDADE: ANÁLISE DA COORTE DE NASCIMENTOS GUARU-YÁ.","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Maternal and Neonatal Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Anemia; Pregnancy; Hemoglobin; Cohort; Prenatal care","score_opus":0.02212350122458442,"score_gpt":0.3592898569826157,"score_spread":0.3371663557580313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415669037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974776,0.0060484484,0.00018569059,0.0042395983,0.00061120617,0.00097,0.000044248136,0.000172255,0.012952505],"genre_scores_gemma":[0.9583041,0.014773484,0.00010972858,0.0068589034,0.00006286864,0.00015540491,0.000030800802,0.000030410454,0.01967429],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976049,0.00054365187,0.00055088167,0.00043153093,0.00017748201,0.0006915695],"domain_scores_gemma":[0.9990504,0.0002444069,0.00013814734,0.00028067813,0.00008171214,0.00020469612],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040033422,0.0002703165,0.000503294,0.00013046943,0.0007525427,0.000016689355,0.00021672345,0.00054912106,0.002618464],"category_scores_gemma":[0.000006400971,0.00021682325,0.00008843108,0.00017475324,0.000084178595,0.00007011655,0.000051345512,0.0006664049,0.00009411697],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004191237,0.00091137935,0.7779631,0.009368449,0.00019788794,0.00042649749,0.026290957,0.0000011907628,0.073528305,0.01979771,0.033893205,0.05343009],"study_design_scores_gemma":[0.029603733,0.000889809,0.19033316,0.004086083,0.00019457426,0.00030729224,0.014348525,0.000497179,0.26635996,0.020666033,0.47077578,0.0019378775],"about_ca_topic_score_codex":0.0009777902,"about_ca_topic_score_gemma":0.00028872988,"teacher_disagreement_score":0.5876299,"about_ca_system_score_codex":0.0000803024,"about_ca_system_score_gemma":0.00019075489,"threshold_uncertainty_score":0.9982933},"labels":[],"label_agreement":null},{"id":"W4415669274","doi":"10.1016/j.htct.2025.104548","title":"GERMLINE PREDISPOSITION TO MYELOID MALIGNANCIES: A COMPREHENSIVE ANALYSIS OF CEBPA, DDX41 AND RUNX1","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"CEBPA; RUNX1; Germline; Myeloid; Myeloid leukemia; Germline mutation; ETV6; Mutation; Gene","score_opus":0.0140609083902808,"score_gpt":0.2959140025763212,"score_spread":0.28185309418604043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415669274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98797375,0.004091002,0.0032490208,0.0030313462,0.00003938765,0.0006524704,0.000019378704,0.000032936015,0.00091068324],"genre_scores_gemma":[0.98283195,0.013156797,0.00077722495,0.0023448968,0.000011159715,0.00004619284,0.00004110149,0.000012721262,0.00077796314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882275,0.0000924227,0.00033250643,0.00036580063,0.00015262864,0.00023386483],"domain_scores_gemma":[0.99922174,0.00016780914,0.000043752803,0.00025526725,0.00016917061,0.00014222901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014048154,0.00016792557,0.000735186,0.00067890086,0.00009306108,0.000008147764,0.000068031775,0.00017878678,0.00019020049],"category_scores_gemma":[0.000008602256,0.00013698173,0.00011925722,0.0009407364,0.0001832042,0.000029404548,0.000029598092,0.00017390646,0.0000026856012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033135682,0.00039633835,0.0461902,0.00049698487,0.0011761363,0.00006357514,0.0027453396,0.000015035285,0.93327004,0.0017380819,0.00076874864,0.009825977],"study_design_scores_gemma":[0.015039904,0.0019295263,0.3858634,0.00041165928,0.0020029158,0.00022893655,0.002673807,0.003928016,0.57286,0.0003273147,0.014267583,0.00046692637],"about_ca_topic_score_codex":0.00008545671,"about_ca_topic_score_gemma":0.00003445929,"teacher_disagreement_score":0.36041,"about_ca_system_score_codex":0.000027322092,"about_ca_system_score_gemma":0.00008690427,"threshold_uncertainty_score":0.5585953},"labels":[],"label_agreement":null},{"id":"W4415669720","doi":"10.1016/j.htct.2025.104870","title":"UPDATED RESULTS OF SONROTOCLAX + DEXAMETHASONE, AN ALL-ORAL TREATMENT, IN PATIENTS WITH T(11;14)-POSITIVE RELAPSED/REFRACTORY MULTIPLE MYELOMA","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Discontinuation; Multiple myeloma; Cohort; Adverse effect; Refractory (planetary science); Dexamethasone; Cohort study; Retrospective cohort study","score_opus":0.01810491532816009,"score_gpt":0.2925487832883246,"score_spread":0.2744438679601645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415669720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559206,0.0003772178,0.00006645774,0.00025189325,0.000038576054,0.0025324177,0.00008086053,0.000042190877,0.0010183428],"genre_scores_gemma":[0.9966024,0.0012214426,0.0007852799,0.00018121702,0.000004873838,0.00016234093,0.000552334,0.000026162365,0.00046394017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981295,0.0002939718,0.0004281881,0.0005358932,0.0002180158,0.00039443054],"domain_scores_gemma":[0.9989882,0.00020425137,0.000094731826,0.00037555041,0.00013712577,0.0002001553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015101177,0.00030421492,0.0006960185,0.00033539982,0.00008678745,0.000009595924,0.00008368751,0.00024310437,0.00008530804],"category_scores_gemma":[0.00001728458,0.00020674092,0.00008102009,0.0003035354,0.00020025129,0.00010611217,0.000012849946,0.00019878699,0.0000035618034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046509523,0.006389788,0.9062664,0.000060298633,0.0003288246,0.00013877565,0.0012575557,0.000001982371,0.006171736,0.000060584287,0.00008228303,0.032732256],"study_design_scores_gemma":[0.11223222,0.007842262,0.7905933,0.00016353234,0.000084727006,0.000014340993,0.0002582868,0.00021740326,0.08638997,0.000033395107,0.001958801,0.00021175017],"about_ca_topic_score_codex":0.0009938173,"about_ca_topic_score_gemma":0.001530758,"teacher_disagreement_score":0.11567308,"about_ca_system_score_codex":0.00008174169,"about_ca_system_score_gemma":0.00015685674,"threshold_uncertainty_score":0.843065},"labels":[],"label_agreement":null},{"id":"W4415669826","doi":"10.1016/j.htct.2025.104184","title":"RELAÇÕES ENTRE CINESIOFOBIA E PARÂMETROS CLÍNICOS EM PACIENTES COM DOENÇA FALCIFORME","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MEDLINE; Reference values; Context (archaeology); Psychiatric comorbidity","score_opus":0.013204501641045849,"score_gpt":0.27979661711661774,"score_spread":0.2665921154755719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415669826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774628,0.014102327,0.0006698184,0.0033135854,0.00020090614,0.00066872814,0.000005176114,0.00010802099,0.0034686206],"genre_scores_gemma":[0.9746101,0.017687565,0.00015538317,0.0002511098,0.000008453339,0.000044883527,0.000029890662,0.000022087856,0.0071905553],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984024,0.00010136375,0.0003469241,0.00043949086,0.0002403296,0.00046945515],"domain_scores_gemma":[0.9992162,0.00014710065,0.00004100724,0.00035484985,0.00007981349,0.00016103094],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019479453,0.0002470761,0.00056524255,0.00025828154,0.00022916398,0.000026793019,0.00012377347,0.00021688986,0.0012176721],"category_scores_gemma":[0.000013144016,0.0001810952,0.00016129205,0.00040628255,0.00020281153,0.000053007585,0.000028406908,0.0003630439,0.000049982522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006023201,0.0041455287,0.42124072,0.010561519,0.0007933516,0.00070228294,0.006715501,0.0000018998645,0.43711588,0.015044938,0.032216508,0.06543866],"study_design_scores_gemma":[0.07211328,0.0061387797,0.12602139,0.004496906,0.00047184486,0.0029853587,0.015981719,0.0025412505,0.6834388,0.0044849995,0.07946696,0.0018587529],"about_ca_topic_score_codex":0.000021346537,"about_ca_topic_score_gemma":0.000009083983,"teacher_disagreement_score":0.29521933,"about_ca_system_score_codex":0.000035138808,"about_ca_system_score_gemma":0.00016450956,"threshold_uncertainty_score":0.99969536},"labels":[],"label_agreement":null},{"id":"W4415669975","doi":"10.1016/j.htct.2025.105634","title":"DIVERSIDADE DE GENÓTIPOS DE GRUPOS SANGUÍNEOS EM PACIENTES BRASILEIROS COM DOENÇAS FALCIFORMES E ANÁLISE COMPARATIVA DE DADOS GLOBAIS: IMPLICAÇÕES PARA SEGURANÇA TRANSFUSIONAL","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genotype; Cochrane Library; Cohort; Risk stratification","score_opus":0.012075463285905835,"score_gpt":0.2761301076058792,"score_spread":0.2640546443199734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415669975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723256,0.010344727,0.010070673,0.003941562,0.0001270346,0.0009478509,0.000040812538,0.00017366686,0.002028031],"genre_scores_gemma":[0.97706604,0.017956508,0.00066127174,0.0037289092,0.000021710466,0.000064193126,0.00004241072,0.000030459109,0.0004284834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783593,0.00020607516,0.00044657307,0.00052876695,0.00021750228,0.00076517585],"domain_scores_gemma":[0.999032,0.00017036087,0.000068856985,0.00030732306,0.00007265005,0.00034878586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023605188,0.0004080878,0.0007152665,0.00021253672,0.0005390669,0.000031723837,0.00018294262,0.0005300821,0.00044639807],"category_scores_gemma":[0.000010437387,0.000325115,0.00028754218,0.0003734922,0.00034966614,0.000079678466,0.00002633403,0.00052097486,0.000013722671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004904844,0.0019618042,0.38630083,0.00075771153,0.0005470859,0.00040463288,0.02528005,0.00002591762,0.5449752,0.00198313,0.0049745105,0.027884256],"study_design_scores_gemma":[0.04519138,0.002091817,0.21106328,0.0012479485,0.0009498288,0.005306084,0.03324208,0.0061648716,0.66188973,0.0029129386,0.02822875,0.0017112981],"about_ca_topic_score_codex":0.00017709885,"about_ca_topic_score_gemma":0.000051967363,"teacher_disagreement_score":0.17523755,"about_ca_system_score_codex":0.00007803059,"about_ca_system_score_gemma":0.00033955605,"threshold_uncertainty_score":0.99992007},"labels":[],"label_agreement":null},{"id":"W4415670529","doi":"10.1016/j.htct.2025.104918","title":"AVALIAÇÃO FUNCIONAL APÓS ARTROPLASTIA TOTAL DE JOELHO NA HEMOFILIA: UM RELATO DE CASO","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteoarthritis; Total knee replacement; Knee Joint","score_opus":0.01580774039630032,"score_gpt":0.2863503407494955,"score_spread":0.27054260035319516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415670529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98143363,0.0045991344,0.0009708493,0.004830986,0.00015185925,0.00041853718,0.000006362317,0.00007766016,0.007510995],"genre_scores_gemma":[0.9778385,0.0060120197,0.00047777055,0.0009461035,0.000041696385,0.00004705325,0.00002099596,0.000021722299,0.0145941125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862957,0.00012331268,0.00023765801,0.00035012534,0.00018886648,0.000470496],"domain_scores_gemma":[0.9993119,0.00016713406,0.000022997026,0.00020963521,0.000056587847,0.0002316923],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024392385,0.00021119039,0.00040725662,0.00016718952,0.00022722183,0.000013472914,0.000061682214,0.00033798846,0.0009524096],"category_scores_gemma":[0.000013472656,0.00015800919,0.0001437805,0.0001842642,0.00017885503,0.000032226166,0.00001725654,0.00039934015,0.000048931448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005024766,0.0021645299,0.428563,0.00060577906,0.0005045342,0.0017819487,0.002398825,0.0000057850652,0.5065563,0.006886099,0.008569996,0.03693846],"study_design_scores_gemma":[0.043104347,0.0031020227,0.14071928,0.0006617574,0.00045273328,0.009236761,0.0016523759,0.0037210071,0.7421387,0.0034354,0.050796833,0.0009787758],"about_ca_topic_score_codex":0.00003471846,"about_ca_topic_score_gemma":0.00001839343,"teacher_disagreement_score":0.28784373,"about_ca_system_score_codex":0.0000632441,"about_ca_system_score_gemma":0.00032849095,"threshold_uncertainty_score":0.99996084},"labels":[],"label_agreement":null},{"id":"W4415670870","doi":"10.1016/j.htct.2025.104471","title":"DESAFIOS NA ELEGIBILIDADE PARA TRATAMENTO INTENSIVO DA LEUCEMIA MIELOIDE AGUDA NO SISTEMA ÚNICO DE SAÚDE: UM RELATO DE CASO","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Palliative care; Intensive care unit; Anamnesis; Nursing care; Neutropenia","score_opus":0.021988625416543024,"score_gpt":0.30900214629967976,"score_spread":0.28701352088313675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415670870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97501534,0.007583007,0.002202629,0.0053051314,0.0001655338,0.0010377934,0.0000064286314,0.00014413403,0.008540027],"genre_scores_gemma":[0.96330565,0.018435473,0.0016926123,0.0083567565,0.00005800752,0.00014268818,0.00002732767,0.00006204425,0.007919457],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972199,0.0003480946,0.0005905806,0.0007165582,0.00027159438,0.0008532741],"domain_scores_gemma":[0.99826044,0.0004307128,0.000078576304,0.00064885896,0.00019639256,0.00038501833],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067478325,0.00040095032,0.00087212,0.00027914607,0.0002633455,0.000045855955,0.00025063008,0.0006300971,0.0005612682],"category_scores_gemma":[0.00009101524,0.00033614587,0.00023178884,0.00040606887,0.0003393098,0.00007734311,0.00004622591,0.0010084303,0.00007347475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073008533,0.0011313455,0.06383554,0.0012827265,0.00047299222,0.0014575575,0.003384456,0.0000039033343,0.87945193,0.002699836,0.01991843,0.019060435],"study_design_scores_gemma":[0.023047866,0.0018633603,0.01329927,0.0009620342,0.0003325379,0.0043034456,0.0025520993,0.0022561562,0.8407209,0.0008157334,0.10898939,0.0008572301],"about_ca_topic_score_codex":0.0002763839,"about_ca_topic_score_gemma":0.00008286896,"teacher_disagreement_score":0.08907096,"about_ca_system_score_codex":0.00034022282,"about_ca_system_score_gemma":0.00083513494,"threshold_uncertainty_score":0.99990904},"labels":[],"label_agreement":null},{"id":"W4415671112","doi":"10.1016/j.htct.2025.104836","title":"HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRANSPLANT-INELIGIBLE OR TRANSPLANT-DEFERRED NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) IN THE PHASE 3 CEPHEUS TRIAL","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Multiple myeloma; Quality of life (healthcare); Bortezomib; Population; Clinical trial; Phases of clinical research","score_opus":0.03849506143546937,"score_gpt":0.33214157402619215,"score_spread":0.2936465125907228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415671112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99290967,0.0017773561,0.00012615343,0.001517205,0.00006832102,0.0032907808,0.00008561868,0.000028563394,0.00019634588],"genre_scores_gemma":[0.99334943,0.00561529,0.00007286935,0.0005105884,0.0000061360397,0.00018077648,0.00019878602,0.00001753367,0.000048607944],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99715424,0.0006777421,0.00096586696,0.00041269846,0.00033273632,0.00045672673],"domain_scores_gemma":[0.9987032,0.0006555301,0.00012114964,0.0003013781,0.000048074,0.00017067566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005414277,0.00027548484,0.001094505,0.00031931401,0.00010356093,0.000009631737,0.00014090097,0.00021045882,0.000107482054],"category_scores_gemma":[0.000034543664,0.00015468404,0.00011025907,0.0005603545,0.00015061919,0.0000526488,0.0000044170656,0.0003532512,0.00000160027],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4213,0.0074469494,0.551681,0.00042829005,0.00013086319,0.00014167186,0.004399902,0.0000020598827,0.0005359391,0.000055478427,0.000036444646,0.013841415],"study_design_scores_gemma":[0.54122686,0.0038883947,0.45197403,0.00035207576,0.000030370533,0.0000138563055,0.0004237334,0.00009934162,0.0017092001,0.000035278805,0.00009354497,0.0001533148],"about_ca_topic_score_codex":0.002591788,"about_ca_topic_score_gemma":0.0042311368,"teacher_disagreement_score":0.11992685,"about_ca_system_score_codex":0.000028413831,"about_ca_system_score_gemma":0.00032406746,"threshold_uncertainty_score":0.6307832},"labels":[],"label_agreement":null},{"id":"W4417153116","doi":"10.1016/j.htct.2025.106225","title":"Obstetrical use of intravenous immunoglobulin: A single-centre retrospective study","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Electricity Association; Canadian Blood Services; Ottawa Hospital; University of Ottawa","funders":"Canadian Blood Services","keywords":"Retrospective cohort study; Pregnancy; MEDLINE; Clinical Practice","score_opus":0.02008501079346034,"score_gpt":0.2547784647330499,"score_spread":0.23469345393958954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417153116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925188,0.004900346,0.00008468321,0.000388426,0.00010062603,0.00080192176,0.0000045008314,0.00003207949,0.0011686211],"genre_scores_gemma":[0.9963317,0.0027012445,0.0001235531,0.00023939137,0.0000031957716,0.000010492925,0.000006451177,0.000009939543,0.0005740662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991457,0.00006189842,0.00025383435,0.00026389156,0.00010725586,0.0001674601],"domain_scores_gemma":[0.99956775,0.0000831641,0.000043200544,0.00018695452,0.00006645081,0.000052486488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033998193,0.000150809,0.0005639373,0.00013015798,0.000072648814,0.000008348354,0.000038011338,0.00012631544,0.0001093172],"category_scores_gemma":[0.00001274075,0.00011451593,0.00008070953,0.0002721003,0.00008307748,0.000028649349,0.000010209338,0.00013542792,0.0000027887443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005540047,0.029716942,0.87568575,0.00016724806,0.0010106335,0.0014519376,0.008980378,7.055987e-7,0.035995502,0.0010858012,0.00034559832,0.040019482],"study_design_scores_gemma":[0.102536894,0.017055254,0.7003548,0.0005261169,0.0011092877,0.00089173816,0.014683365,0.00014269668,0.15159832,0.0019351719,0.008306369,0.00085995765],"about_ca_topic_score_codex":0.00006319616,"about_ca_topic_score_gemma":0.000026057669,"teacher_disagreement_score":0.17533089,"about_ca_system_score_codex":0.000026043008,"about_ca_system_score_gemma":0.000037516664,"threshold_uncertainty_score":0.46698242},"labels":[],"label_agreement":null},{"id":"W4417521103","doi":"10.1016/j.htct.2025.106219","title":"WHY I CHOSE HEMATOLOGY ?","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Subspecialty; Internship; Hematology; Medical school; Medical laboratory; Indictment","score_opus":0.01115393982972843,"score_gpt":0.27122825015598406,"score_spread":0.2600743103262556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417521103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90291554,0.021729136,0.00087378104,0.037645746,0.0002817473,0.00053862436,0.000001766118,0.0001507958,0.035862885],"genre_scores_gemma":[0.9322196,0.04023267,0.00095434696,0.021499828,0.000024854276,0.00006353304,0.000017770637,0.000022945842,0.004964449],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990764,0.000054983368,0.00022845907,0.00032491513,0.00007539233,0.00023979893],"domain_scores_gemma":[0.9995317,0.00007528943,0.000027774504,0.00023224964,0.000034077904,0.00009890154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007001686,0.00018592195,0.0004703087,0.00012024465,0.00013256854,0.0000071480317,0.000049783386,0.00022008458,0.00087275106],"category_scores_gemma":[0.0000036231975,0.00013754623,0.00010504374,0.00014652789,0.0001760449,0.00001918373,0.000011279031,0.00017615451,0.000024635418],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006326559,0.0093048,0.26771984,0.002346493,0.0009829671,0.0020035584,0.005062607,8.8377186e-7,0.23295006,0.16463035,0.18062718,0.12804471],"study_design_scores_gemma":[0.019781243,0.0010447403,0.0043295375,0.00031963165,0.0001540573,0.0019380088,0.000999909,0.000048438113,0.48903418,0.0026870891,0.47930998,0.0003531963],"about_ca_topic_score_codex":0.000036278474,"about_ca_topic_score_gemma":0.000017243692,"teacher_disagreement_score":0.29868278,"about_ca_system_score_codex":0.000012165636,"about_ca_system_score_gemma":0.000049814396,"threshold_uncertainty_score":0.9556012},"labels":[],"label_agreement":null}]}